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The etiologic agent of tuberculosis (TB), Mycobacterium tuberculosis (Mtb) 
infects more than one-third of the world population, resulting in two million deaths 
annually. The success of this pathogen relies on its ability to go into a nonreplicating 
persisting (NRP) state upon infecting an immunocompetent human host. Intriguingly, 
the metabolic processes that are critical for Mtb to enter dormancy, survive in this 
NRP state, and reactivate upon favorable conditions are poorly characterized. Of note, 
hypoxia is postulated to be a key factor that triggers the NRP state in the bacilli.  
Mycobacteria store large amounts of triacylglycerols (TGs), probably as 
energy reserves during periods of oxygen-limited stress. The kinetics and importance 
of TG metabolism at various different physiological states (logarithmic growth, 
aerated stationary phase, hypoxia-induced dormancy, regrowth from dormancy) are, 
however, not clearly understood.  
In this study, we specifically determined the levels of TG accumulation and 
TG lipase activity during different metabolic states in Mycobacterium bovis bacillus 
Calmette-Guérin (BCG), an attenuated tubercle bacilli, closely related to Mtb. We 
found extensive buildup and breakdown of TGs in the bacillus during entry into and 
exit from hypoxic dormancy, respectively. These processes correlate with the 
dynamic presence of intracellular lipid inclusions. Reduction of TGs also coincides 
with an increase of cellular TG lipase activity in the regrowing bacilli. 
Tetrahydrolipstatin, an inhibitor of TG lipases, reduces total lipase activity, prevents 
breakdown of TGs, and blocks the growth of mycobacteria upon resuscitation with 
air. Our results demonstrate that the utilization of TGs is essential for the regrowth of 
bacilli during exit from the hypoxic dormancy. However, enzymes involved in the 
anabolism and catabolism of mycobacterial TG inclusions remain relatively unknown. 
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Intracellular TG inclusions known as lipid droplets (LDs) are associated with 
the bacilli in TB patient sputum samples and hypervirulent strains. A LD comprises a 
hydrophobic core of mainly TGs, enveloped by phospholipid monolayer with few 
embedded proteins related to the metabolism of lipid inclusions. Although proteins 
bound to LDs are well characterized in eukaryotes, the identities and functions of such 
proteins have not been described in mycobacteria. Here, we identified five proteins, 
Tgs1 (BCG3153c), Tgs2 (BCG3794c), BCG1169c, BCG1489c and BCG1721, which 
are exclusively associated with LDs purified from hypoxic dormant M. bovis BCG. 
Disruption of genes tgs1, tgs2, BCG1169c, BCG1489c in mycobacteria revealed that 
they are indeed involved in the TG metabolic pathway. We characterized BCG1721, 
an essential bi-functional enzyme capable of promoting buildup and hydrolysis of 
TGs, depending on the metabolic state. Nonreplicating mycobacteria overexpressing a 
BCG1721 construct with an inactive lipase domain displayed a phenotype of 
attenuated TG breakdown and regrowth upon resuscitation. In addition, by 
heterologous expression in baker’s yeast, it is found that these mycobacterial proteins 
co-localized with host LDs, and complemented a lipase-deficient yeast strain, 
indicating that neutral lipid deposition and homeostasis in eukaryotic and prokaryotic 
microorganisms are functionally related. The demonstrated functional role of 
BCG1721 in mycobacterial growth during reactivation makes this novel LD-
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1.1 Tuberculosis and Mycobacteria 
1.1.1 Epidemiology of tuberculosis (TB) 
Tuberculosis (TB), a chronic and debilitating disease, remains a global threat 
despite the widespread use of the bacillus Calmette-Guérin (BCG) vaccine and 
antibiotic treatment. Its etiologic agent, Mycobacterium tuberculosis (Mtb), has been 
estimated to infect almost a third of the world’s population and kills two million 
people annually (Dye, 2006). Majority of the cases occur in less-developed countries, 
and has been particularly severe since the 1990s when TB incidence increased 
significantly in Africa as a result of human immunodeficiency virus (HIV) co-
infection (Corbett et al, 2003). Owing to socio-economic changes and decline of the 
healthcare system for the past decade, the former Soviet Union similarly suffered new 
surges of TB incidence (Frieden et al, 2003).  
World Health Organization (WHO) estimates 9.4 million new TB cases in 
2008 (139 per 100,000 population), including 4.1 million (61 per 100,000 population) 
new smear-positive cases: the most infectious form of disease (WHO Report, 2009). 
These numbers include TB in HIV-positive people. Asia (Southeast Asia and Western 
Pacific region) accounts for 55% of all global cases, and Africa, second in line, 
accounts for 30%. On the other hand, case numbers have declined at a steady rate in 
western and central Europe, North and South America and the Middle East (Figure 
1.1). Disproportionate aggregation of TB cases in poorer nations has remained very 
much unchanged for the past decade, showing the imperative need for affordable new 





Figure 1.1: Estimated TB incidence rates, by country, 2008. (Source: WHO 
Report, 2009) 
 
1.1.2 Biology of mycobacteria 
The genus Mycobacterium is currently known to comprise more than 100 
species (Tortoli, 2006). Most species are free-living saprophytes, with only a minority 
as human pathogens causing TB, and leprosy (Ryan and Ray, 2010). The cultivable 
members of Mycobacterium are clinically grouped either as the Mtb complex or the 
nontuberculous (atypical) mycobacteria. Whereas, M. leprae, which causes leprosy, is 
an obligate parasite and therefore not cultivable in vitro (van Beers et al, 1996).  
The members of the Mtb complex include Mtb, M. bovis, M. africanum, M. 
microti and M. canettii. The diseases caused by these subspecies are clinically very 
similar. Pulmonary diseases caused by Mtb and M. bovis are clinically, 
radiographically, and pathologically indistinguishable. However, M. bovis appears to 
have a diminished propensity to reactivate and spread from person to person (O'Reilly 
and Daborn, 1995). By continuous passaging through artificial media, Calmette and 
Guérin attenuated a strain of M. bovis to generate BCG, which is used as a vaccine.  
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Mycobacteria are aerobic and nonmotile rods that are weakly Gram-positive 
and acid-fast on Ziehl-Neelsen staining. The bacilli belong to the actinobacteria (GC-
rich DNA) family, and have a variable size between 0.2-0.6 μm wide by 1.0-10 μm 
long. All Mycobacterium species share a characteristic cell wall, thicker than other 
bacteria, which is hydrophobic, waxy and rich in mycolic acids (see Section 1.1.3). In 
the laboratory, Mtb can be grown on the agar-based Middlebrook medium or the egg-
based Lowenstein-Jensen medium (Parish and Stoker, 1998). Since it has a slow 
generation time of around 18-20 hours, it takes 3-6 weeks for the bacteria to form 
visible colonies on these solid media (Parish and Stoker, 1998). 
 
1.1.3 Mycobacterial lipids 
The current genome annotation of Mtb consists of approximately 4,000 
predicted proteins, classified into 11 distinct protein groups (Camus et al, 2002), 48% 
of which have no known function. Comparative sequence analysis of the genome has 
shown that mycobacteria encode a remarkably wide range of proteins involved in 
lipid metabolism, which is unrivalled in the whole prokaryotic world. In Escherichia 
coli, for example, approximately 50 enzymes are involved in lipid metabolism, 
whereas the Mtb genome contains at least 250 genes encoding for these enzymes 
(Cole et al, 1998). Since lipids account for 60% of the dry weight of the bacillus, lipid 
metabolism can be assumed to be one of the major pathways in mycobacteria.  
Mycobacteria possess a cell wall with a complex and unique structure, 
particularly rich in lipids (Figure 1.2), amounting to 30-60% of the dry weight (Daffe 
and Draper, 1998). Hence, considerable research has been focusing on the lipids 
present in the cell wall. This cell envelope with a most unusual composition of lipids, 
is known to confer unique structural properties that aid in the diagnosis of clinical 
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specimens. The lipids attached to the cell wall are also important in directing host-
pathogen interactions (Brennan and Nikaido, 1995), as well as providing the bacilli 
with a protective barrier against breakage, antibiotics and the macrophage’s 
bactericidal attacks (Gao et al, 2003). Since the cell wall is hydrophobic and highly 
impermeable, it is noteworthy that proteins secreted across the mycomembrane 
require a specialized secretion system (Abdallah et al, 2007). Some important 




Figure 1.2: Schematic representation of the mycobacterial cell envelope. The cell 
wall is mainly composed of a large cell-wall complex that contains three different 
covalently linked structures (peptidoglycan (grey), arabinogalactan (blue) and 
mycolic acids (green)).The covalent linkage of mycolic acids results in a hydrophobic 
layer of extremely low fluidity. This layer is also referred to as the mycomembrane. 
The outer part of the mycomembrane contains various free lipids, such as phenolic 
glycolipids, phthiocerol dimycocerosates, cord factor or dimycolyltrehalose, 
sulpholipids and phosphatidylinositol mannosides, that are intercalated with the 
mycolic acids. Most of these lipids are specific for mycobacteria. The outer layer, 
which is generally called the capsule, mainly contains polysaccharides (glucan and 
































































































































































































































































































































































































































































































































































































































































































































































































































































































1.1.4 Latency of TB disease 
After inhalation of air-borne droplet nuclei containing Mtb, it is estimated that 
30% of individuals do get infected and of these, 40% develop active TB with 
microscopic observation of viable bacteria in the sputum (Parrish et al, 1998). 
Symptomatically, these infected individuals may have persistent fatigue, anorexia, 
progressive weight loss, low-grade fever, and a chronic cough.  
The rest of the Mtb-infected people (60%) show no clinical symptoms and do 
not transmit the disease. However, they either have a delayed-type hypersensitivity 
reaction when subcutaneously challenged with purified protein derivative (PPD) of 
Mtb, or possess a chest radiograph that demonstrates scars indicative of previous TB 
infections. In such individuals, a residual population of viable bacteria may be 
maintained in a poorly understood state of clinical latency for extended periods of 
time (Lillebaek et al, 2002). These people with latent TB infection (LTBI) are 
“reservoirs” for reactivation of the bacilli (2-23% lifetime risk) (Gedde-Dahl, 1952). 
However, this risk increases up to 10% annually if the immune system becomes 
suppressed, as is frequently observed in individuals coinfected with the HIV (Corbett 
et al, 2003; McShane, 2005). The synergy of TB and HIV is deadly as TB kills more 
HIV-positive patients than any other opportunistic infection, accounting for about 
30% of global AIDS deaths (McShane, 2005). Other factors associated with the 
likelihood of Mtb reactivation from latency are conditions known to compromise the 
immune system such as steroid therapy, age, and malnutrition (Styblo, 1991). The 




Figure 1.3: Outcomes associated with exposures to Mtb. (Source: Parrish et al, 
1998) 
 
1.1.5 Pathogenesis of TB infection 
Most commonly, Mtb spreads when an infected patient expels small droplets 
that contain the bacilli during sneezing, coughing or talking. The most infective 
droplet is around 1-3 μm in diameter (large droplets do not remain airborne for long 
and do not reach the alveoli to establish an infection) and contains up to three bacilli 
(Grosset, 2003; Riley et al, 1962; Riley, 1974). Transmission is dependent on the 
number of infectious droplets expelled by the carrier, the duration of exposure, and 
the virulent strength of the invading mycobacterial strain.  
Infection of Mtb occurs via inhalation of the bacillus into a pulmonary 
alveolus. Within the lungs, Mtb primarily infects and resides in resident phagocytic 
cells such as alveolar macrophages and dendritic cells. Dendritic cells play a very 
important role in this early stage of infection, since they are much better antigen 
presenting cells than macrophages (Tascon et al, 2000). In addition, they are reported 
to be important in activating T-cells (Bodnar et al, 2001; Gonzalez-Juarrero and 
Orme, 2001) and disseminating the bacilli due to their migratory feature (Lipscomb 
and Masten, 2002).  
Mtb is phagocytosed upon binding to a macrophage mannose and/or 
complement receptor (Schlesinger, 1993). Within the host macrophage, the tubercle 
bacilli initially reside within an endocytic vacuole called the phagosome. The normal 
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progression of the phagosome is characterized by phagosome-lysosome fusion, along 
with various alterations in the environment. The milieu becomes very hostile and the 
mycobacteria encounter acidic pH, free radicals [e.g. reactive nitrogen intermediates 
(RNI)], lysosomal enzymes, and toxic peptides. Particularly, RNI are very effective 
against Mtb in activated murine macrophages (Chan et al, 1992; Chan et al, 1995). It 
is also observed that resistance to RNI correlates well with the virulence of 
mycobacterial strains (O'Brien et al, 1994), highlighting its importance in 
antimicrobial activity. 
Although macrophages in general provide an effective initial barrier against 
pathogens, Mtb has evolved many evasion strategies that allow survival within the 
phagocytic cell (see Section 1.1.6). The mycobacteria multiply exponentially within 
the macrophages (McDonough et al, 1993), and induce cytokines that initiate the 
inflammatory response in the lungs (Grosset, 2003). Macrophages and lymphocytes 
migrate to the site of infection and form a granuloma (also known as tubercle). The 
human granuloma comprises a collection of macrophages surrounded by a ring of 
CD4+ and CD8+ T-lymphocytes that secrete a range of chemokines, cytokines, 
adhesins and integrins to coordinate the recruitment, migration and retention of cells 
in the tubercle (Saunders and Cooper, 2000). The extensive inflammatory response 
within the granulomas may cause tissue necrosis. A balance with host immunity is 
reached when the mycobacterial infection has been controlled, but the bacilli inside 
the granuloma have not been destroyed (Russell, 2001). Viable mycobacteria have 
been isolated from granulomas in the lungs of persons with clinically inactive TB, 
indicating that the organism can persist in a tuberculous lesion for years (Robertson, 
1933).  
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Occasionally, the tubercle bacilli may spread to other parts of the lung or to 
any part of the body via the bloodstream. Pleuritis and lymphadenitis are common, 
but any organ can become infected; the highest mortality are TB meningitis and 
miliary TB. 
 
1.1.6 Survival strategies for mycobacteria within the host 
Many studies have shown that pathogenesis and virulence of Mtb are tightly 
associated with the ability of the bacteria to survive in host macrophages (Russell, 
2001; Vergne et al, 2004). One survival strategy is the inhibition of phagosome-
lysosome fusion, thereby preventing the tubercle bacilli from degradation (Armstrong 
and Hart, 1975; Frehel et al, 1986). It has been observed that phagosomes containing 
pathogenic mycobacteria differ from the ones harboring non-pathogenic strains (Koul 
et al, 2004). For example, many characteristics of early endosomes are retained in 
phagosomes containing pathogenic bacilli. In particular, the pH fails to acidify below 
pH 6.2 (Crowle et al, 1991), and the endosomal compartment remains positive for a 
range of early endosomal markers (Via et al, 1997). One of them is Rab5, a member 
of the small GTPases. It was found that the persistence of Rab5 and the absence of 
Rab7, a marker of the late endosome, is consistent with the arrest of the maturation 
from early to late endosome (Pethe et al, 2004). Another protein, tryptophan-aspartate 
containing coat protein (TACO), was found to be associated with infected cells. It is 
actively retained at the mycobacterial phagosome membrane, thereby preventing 
phagosome-lysosome fusion (Ferrari et al, 1999). Notably, Kupffer cells in the liver, 
which is the major clearance site for mycobacterial infections, lack TACO (Ferrari et 
al, 1999). Overall, how the tubercle bacilli achieve the arrest of phagosomal 
maturation is currently unclear. Data from different groups suggest that more than one 
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mechanism may be responsible for this process of arrest (Koul et al, 2004; Pieters, 
2001). 
Other evasion strategies include the inhibition of apoptosis and stimulation of 
bactericidal responses by interfering with signaling pathways that involve 
phosphatidylinositol 3-kinases (Christoforidis et al, 1999; Wurmser et al, 1999), 
cytokine production (Flynn et al, 1993), and calcium signaling (Jaconi et al, 1990; 
Malik et al, 2001). Antigen presentation also appears to be altered due to the 
interactions of bacterial components with human toll-like receptors, which results in a 
decreased expression of major histocompatibility complex class II molecules (Thoma-
Uszynski et al, 2001).  
 
1.1.7 Diagnosis of active and latent TB 
The current gold standard for diagnosis of active TB is to microscopically 
determine the presence of acid-fact bacilli in patient’s sputum samples following 
isolation of Mtb in culture (Nahid et al, 2006). Other useful TB diagnostic tools 
include chest radiographs, but abnormal X-ray results may also resemble findings 
from other diseases.  
For a long time, the tuberculin or Mantoux test, where PPD of Mtb is injected 
intradermally, was the only method available for diagnosis of latent TB (Nahid et al, 
2006). Although an important tool to diagnose TB, it only indicates that a bacterial 
infection has taken place some time in the past. It does not reveal if the infection is 
currently active. Notably, this test has poor specificity and shows cross-reactivity with 
BCG vaccination (Nahid et al, 2006; Pai, 2005). At present, the tuberculin skin test is 
used to diagnose latent infection in non-immunised individuals (Andersen et al, 2000; 
Frieden et al, 2003).  
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These problems led to the development of new assays such as QuantiFERON-
TB Gold (Cellestis Limited, Australia). It is an in vitro diagnostic assay that measures 
the release of γ-interferon from peripheral blood T-lymphocytes, following 
stimulation with a specific Mtb antigen (ESAT-6). This test has good sensitivity and 
specificity, and is also applicable after a BCG vaccination. However, this test is very 
expensive, therefore it is of limited use in developing countries. Moreover, it is still 
unknown how well this test can measure the risk of reactivation of a latent infection 
(Andersen et al, 2000). Further, polymerase chain reaction (PCR)-based diagnostic 
assays such as Amplicor Mtb test (Roche Diagnostic Systems Inc, United States), 
have also been developed (Nahid et al, 2006). 
Until recently, it is necessary to culture the Mtb strains isolated from patients 
in order to determine the antibiotic susceptibility patterns to design an appropriate 
treatment regimen (Nahid et al, 2006). However, due to the long replication time of 
the pathogenic mycobacteria, treatment is often given prior the release of test results. 
Consequently, numerous kits that rapidly detect drug-resistance based on molecular 
beacons (Lin et al, 2004), and line probes (Morgan et al, 2005) have been designed to 
accelerate this screening process (Nahid et al, 2006). 
 
1.1.8 Preventive measures against TB 
BCG vaccine based on an attenuated M. bovis strain was developed and used 
widely for the prevention of TB. The BCG vaccine was first tested in humans in 1921 
(Bonah, 2005), and has since been shown to confer protection against TB for as long 
as 50-60 years after a single dose in childhood (Aronson et al, 2004). However, this 
protection is variable and is possibly due to exposure to Mtb-like antigens derived 
from environmental mycobacteria (Brandt et al, 2002; Fine, 1995). For example, in 
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India, the vaccine offers little or no protection against pulmonary TB while it is 70% 
effective in the United Kingdom (Brandt et al, 2002; Fine, 1995; Martin, 2006).  
Nevertheless, the BCG vaccine is still very much in use in developing 
countries, especially to prevent development of the deadly form of the disease in 
children (meningitis and miliary TB). It is very safe, cheap and offers a good 
protection to children in terms of dissemination, but is of limited use in adults due to 
inefficient protection. Even though new vaccines have been developed, none of them 
have shown to be significantly better than the BCG vaccine (Frieden et al, 2003).  
Since tubercle bacilli are spread from person to person, early recognition and 
subsequent treatment (including isolation) of active disease is very important. 
Pertaining to this, essential control strategies are implemented such as socio-economic 
improvements in living standards and exposure prophylaxis, e.g. for relatives of a TB 
case (WHO Report, 2009).  
 
1.1.9 Antibiotics against mycobacteria 
The aims of anti-TB therapy are to ensure a cure without relapse, prevent 
death, eradicate Mtb transmission, and prevent the emergence of drug-resistance 
(Frieden et al, 2003). A multi-drug regimen is necessary to minimize the risk of 
emergence of drug-resistance. The first-line drugs available for the treatment of TB 
(Blumberg et al, 2005) are rifampicin (RIF), isoniazid (INH), pyrazinamide (PZA), 
streptomycin (STR) and ethambutol (EMB). Their main properties are their 
bactericidal, sterilizing activity and the prevention of resistance.  
RIF inhibits the activity of the β-subunit of DNA-dependent RNA polymerase, 
which acts early in transcription. By binding the β-subunit in close proximity to the 
RNA/DNA channel, the transit of the growing RNA chain is physically blocked 
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(Campbell et al, 2001). RIF is the most efficient drug in terms of sterilizing activity 
since it is very effective against persistent bacilli in the continuation phase of 
treatment. Potential toxic effects in humans include hepatotoxicity, though is 
generally rare with RIF alone. However, pre-existing conditions can have an 
intensifying effect. For RIF (10 mg/kg), it was reported that clinically apparent liver 
toxicity occurred in 2-5% of cases and altered liver function tests in 10-15% of cases 
(Blumberg et al, 2005).  
INH is a prodrug and is activated by KatG, a catalase-peroxidase hemoprotein 
(Zhang et al, 1992). INH inhibits InhA, a NADH-specific enoyl-acyl carrier protein 
reductase (Mdluli et al, 1998). This process inhibits the synthesis of mycolic acids 
required for the mycobacterial cell wall (Takayama et al, 1975). In humans, INH 
shows a high early bactericidal activity that kills actively growing bacteria. For the 
first two weeks of treatment, INH causes rapid decrease in sputum bacilli. Afterwards, 
the decrease slows down for non-growing bacterial populations. Concerning adverse 
effects in humans, it is noteworthy that INH crosses the placental barrier. This 
requires strict observations of the neonate of an INH-treated mother for any 
anomalous effects (Blumberg et al, 2005).  
PZA is only bactericidal against Mtb in an acidic environment (Zhang et al, 
1999). The mechanism of action of PZA is poorly understood (Raynaud et al, 1999). 
It was found that it inhibits different functions at low pH (Zhang et al, 1999). PZA is 
essential in the treatment of TB meningitis since it crosses inflamed meninges. 
However, since the rate of hepatotoxicity caused by PZA is unacceptably high, the 
drug should not be used to treat latent TB (Blumberg et al, 2005).  
STR is only active against fast-multiplying tubercle bacilli. The mode of 
action for STR is the inhibition of protein synthesis by binding to the conserved A site 
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of the 16S rRNA in the 30S ribosomal subunit (Garvin et al, 1974). STR shows rapid 
development of resistance in humans and has the potential to cause serious neurotoxic 
effects in humans (Blumberg et al, 2005).  
ETH blocks cell-wall biosynthesis by inhibiting arabinosyl transferases 
(Mikusova et al, 1995; Takayama and Kilburn, 1989). This drug is effective against 
actively growing mycobacteria. It is used in combination with other first-line drugs in 
order to avoid the emergence of genetic resistance to the drugs. The most severe toxic 
effects of the drug found in humans include optic neuropathy and occasional 
hepatotoxicity (Blumberg et al, 2005).  
 
1.1.10 Standard treatment regimens 
The current TB chemotherapy evolved from numerous experimental and 
clinical studies primarily conducted between the 1950s and 1970s (Fox et al, 1999). 
The best TB chemotherapy, called DOTS (directly observed treatment, short-course), 
has a cure rate of up to 95% and is recommended by the WHO for treating every TB 
patient (WHO Report, 2009). 
DOTS is a six month therapy consisting of two phases. The initial 2-month 
intensive phase is designed to kill actively growing and semi-dormant bacilli (Frieden, 
1999). At least two bactericidal drugs, INH and RIF are necessary in this phase. PZA 
given in the intensive phase allows the duration of treatment to be reduced from nine 
to six months. The addition of EMB benefits the regimen when initial drug-resistance 
is present or if the burden of Mtb is high.  
This initial phase is followed by a continuation phase, usually a 4-month 
course of RIF and INH. The former kills any residual dormant bacilli and the latter 
kills any RIF-resistant mutants that commence replication. At the end of the therapy 
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regime, patients are considered “cured” but with a possible rate of relapse at 2-3%. In 
cases of infection with drug-resistant strains, a list of second-line drugs and 
injectables are available for treatment. Second line drugs, which are often less 
effective and with higher toxicity, fall under six main classes, namely 
aminoglycosides, polypeptides, fluoroquinolones, thioamides, cycloserine and p-
aminosalicylic acid.  
Although DOTS can cure TB, the lengthy six month therapy makes patient 
compliance difficult, and noncompliance is a frequent source of drug-resistant strains. 
As latent infections are probably caused by tubercle bacilli with very low metabolic 
activity, current TB chemotherapy typically do not affect these mycobacteria. TB is in 
sore need of new drugs, and new targets that are more appropriate to latent infections 
(Barry, III et al, 2000; Dick, 2001; McKinney, 2000). Any chemotherapeutic strategy 
that reduced the length of time needed for treatment would have an important effect 
on cost, compliance and the emergence of drug-resistant strains. 
 
1.1.11 Drug-resistant TB 
DOTS as the standard TB chemotherapy is generally effective, but not 
“always” effective. Although the reasons for treatment failure vary and are always 
tragic, the spread of drug-resistant Mtb is especially alarming. Infection with a Mtb 
strain that is resistant to at least the two first-line TB drugs (RIF and INH), is defined 
as multiple drug-resistant (MDR)-TB (Heifets and Cangelosi, 1999). These strains 
constitute 8.5% of global TB isolates, with 500,000 new cases of emerging worldwide 
in 2007 (WHO Report, 2009).  
A worrying new trend is the emergence of extensively drug-resistant (XDR) 
strains which are additionally resistant to second-line medications (fluoroquinolones), 
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and one or more of three injectable drugs (capreomycin, kanamycin and amikacin). 
XDR-TB cases have been described in at least 17 countries on all continents (US 
Centers for Disease Control and Prevention, 2006).  
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1.2 Latency, Dormancy and Persistence 
1.2.1 Definitions related to chronic TB infection 
The unique ability of Mtb to establish a state of latent infection in the human 
host has been described in the Section 1.1.4. Despite the ability of Mtb to generate a 
productive cell-mediated immune response, the pathogen is capable of persisting 
within the host and to cause a long-term asymptomatic (latent) infection. Latency, 
dormancy and persistence are the terms associated with the description of chronic TB 
(Gomez and McKinney, 2004).  
Latency, generally, is a clinical term describing the asymptomatic stage of a 
human infection. In relation to TB, it was defined as “the presence of any tuberculous 
lesion, which fails to produce symptoms of its presence” (Amberson, 1938). Latent 
cases are typically PPD-positive by tuberculin skin test, but are not contagious to 
others. Without antibiotic treatment, a latent infection is thought to be the classic 
outcome of a TB infection (Gomez and McKinney, 2004).  
Dormancy has been used to describe a particular physiological state of the 
mycobacteria, which is “a reversible state of low metabolic activity, in which cells 
can persist for extended periods without division” (Gomez and McKinney, 2004). 
This term has become strongly associated with an in vitro model of mycobacterial 
growth under limiting oxygen tension (Wayne and Hayes, 1996). It has been 
suggested that this model may mimic the state of Mtb surviving in closed, necrotic 
lesions during clinical latency. However, it should be emphasized that the model 
remains speculative, since the location and physiological state of the tubercle bacilli 
during latency have not been firmly established yet.  
The word persistence literally means “continuing steadfastly or obstinately, 
especially in the face of opposition or adversity”. As a pathogen, Mtb manifests its 
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unusual capacity to persist in many ways. The manifestation of persistence is due to 
(i) the capacity of the pathogen to reside within macrophages, (ii) avoiding 
elimination by the human hosts immune response, and (iii) slowing the rate of 
clearance by anti-TB drugs (Gomez and McKinney, 2004). It is important to note that 
the persisting tubercle bacilli may also be at a state of dormancy.  
 
1.2.2 Latent TB infection 
Patients with latent infection have a cell-mediated immune response that 
controls progression of the infection in the initial focus of infection and in the local 
draining lymph nodes (the “Ghon complex”) by granuloma formation (Boshoff and 
Barry, III, 2005). However, in the absence of actively replicating mycobacteria, there 
is reduced local inflammation and immunological responses (Olsen et al, 2004). The 
nature of the bacterium that lies dormant within the granulomas generates much 
interest, as knowledge of its physiology and metabolic needs in this state could be 
essential to attempt drug targeting against persisting Mtb during clinical latency. 
 
1.2.3 Life within a granuloma 
Granuloma formation is the hallmark of TB infection. Granulomas are 
organized aggregates of immune cells that surround foci of infected tissues (Figure 
1.4). A newly formed granuloma is composed of immature mononuclear phagocytes 
surrounded by lymphocytic effector cells including CD4+ and CD8+ T-cells. During 
maturation into productive granulomas, mononuclear phagocytes differentiate into 
macrophages and become highly activated, aggregating into multinucleated giant 
cells, and larger epithelioid-like cells that contain tightly inter-digitated cell 
 19
membranes. This structure acts like a barricade and limits further dissemination to 
additional sites of infection (Flynn and Chan, 2001; Manabe and Bishai, 2000). 
Within the granuloma, it is generally thought that Mtb must adapt to a highly 
dynamic growth environment. First, the surrounding tissue is either calcified or 
necrotic. Second, the interior of the granuloma contains high carbon dioxide 
concentrations as well as increased levels of aliphatic organic acids and hydrolytic 
enzymes, but is thought to be devoid of oxygen and nutrients. Finally, the activation 
of macrophages and other immune effector cells surrounding the granuloma results in 
the release of numerous antimicrobial compounds (Saunders and Cooper, 2000). 
Although the significance of this environment on Mtb growth and survival during 
latent infection remains relatively unclear, tubercle bacilli are frequently observed 
intracellularly in infected human tissues, hence they are likely to encounter such 




Figure 1.4: Composition of a mature granuloma. The granuloma is the site of 
infection, persistence and pathology. The centre of a granuloma is composed mainly 
of necrotic tissue, multinucleated giant cells (fused macrophages) and epitheloid-like 




1.2.4 Hypoxia and nutrient starvation: possible stress-factors during infection 
It is postulated that granulomas limit Mtb growth by restricting bacterial 
access to oxygen and nutrients and exposing the bacilli to acidic pH and immune 
effectors, like nitric oxide. Hypoxia, or even anaerobiosis, is thought to be the 
prevailing condition in granulomas, at least in guinea pigs, rabbits, non-human 
primates, and human beings (Aly et al, 2006; Via et al, 2008). Moreover, there are 
several lines of evidence supporting the probability that hypoxic conditions do exist in 
human TB lesions. In inflammatory or necrotic regions, there is a state of depleted 
oxygen (Imboden and Schoolnik, 1998). In human TB, the bacilli are predominantly 
extracellular (Grosset, 2003), but tubercle bacilli have been cultivated readily from at 
least 20% of old blocked lesions (Hurford and Valentine, 1957; Medlar et al, 1952; 
Salkin and Wayne, 1956). TB lesions are essentially avascular (Russell et al, 1955), 
so a blocked lesion has restricted access to oxygen. From more than 90% of closed 
lesions from patients, only about half of them yielded positive cultures, and only 
about 0.1% of the number of bacilli appeared on the smears grew on culture (Salkin 
and Wayne, 1956). Carbon dioxide produced in necrotic tissue may enhance the 
bactericidal effect of anaerobiosis on Mtb (Dubos, 1953). Although pulmonary 
alveolar macrophages have access to atmospheric air, macrophages encountered in 
later stages of infection are facultative anaerobes and respire in low oxygen tension 
(Pearsall and Weiser, 1970).  
 Other than hypoxia, there is also evidence to suggest that persisting bacilli in 
lung lesions suffer nutrient limitation. Mtb isolated from lung lesions has been found 
to display altered morphology and staining properties compared with bacilli grown in 
vitro (Nyka, 1974). Mycobacterial cultures starved in distilled water were found to 
display these same properties but regained acid-fastness and started growing when 
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added to nutrient-rich medium, even after a two-years starvation period (Nyka, 1974). 
Mycobacterium smegmatis, a saprophytic fast-growing species, starved of carbon, 
nitrogen or phosphorous has been shown to remain viable for over 650 days after an 
initial decline in colony-forming units and displayed increased stress-resistance, 
increased mRNA stability and an overall decrease in protein synthesis (Smeulders et 
al, 1999). Furthermore, comparison of the transcriptional profiles of Mtb in an in vitro 
multiple-stress model (Deb et al, 2009) with those reported previously using single-
stress applications such as nutrient depletion (Betts et al, 2002), acidic shock (Fisher 
et al, 2002) and hypoxia (Park et al, 2003) indicates that nutrient starvation plays a 
bigger role in the expression of a larger number of stress-responsive genes (related to 
dormancy) than the other stresses did (Deb et al, 2009). Collectively, mycobacterial 
latency might also be an adaptation to a lack of nutrients experienced by the pathogen 
in the granulomas.  
 
1.2.5 Model systems of persistent infection 
Much is known about host factors restricting Mtb growth during latent stages 
but very little is known about the bacterial factors required for persistent infection. 
This is due to, at least in part, the difficulties in experimentally recreating conditions 
encountered by the tubercle bacilli during periods of latency in the host, resulting in 
the inability to clearly define the physiological state of Mtb for the identification of 
relevant genetic determinants required for its persistence.  
Nonetheless, a variety of systems have been established to address the 
question cited above. Although these models are limited in their ability to fully 
recapitulate host and bacterial characteristics, they are able to mimic certain aspects of 
latent infection (Boshoff and Barry, III, 2005). The most widely used in vivo models 
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are Cornell mouse model (McCune, Jr. et al, 1956; McCune, Jr. and Tompsett, 1956; 
McCune et al, 1966) and low-dose murine model (Orme, 1988), whereas in vitro 
systems include Wayne nonreplicating persistence model (Wayne and Hayes, 1996) 
and nutrient starvation model (Betts et al, 2002). Of particular interest, only Wayne 
dormancy model will be discussed in the next section. 
 
1.2.5.1 The Wayne nonreplicating persistence model 
The “nonreplicating persistence (NRP)” model is based on the assumption that 
Mtb encounters hypoxic or anaerobic conditions during its residence within 
granulomatous lesions in the human host (Wayne and Hayes, 1996). It is an in vitro 
model that relies on a self-generated oxygen gradient by incubation in sealed cultured 
tubes with a defined culture-to-headspace ratio and gentle stirring. Such progressive 
oxygen limitation terminates bacterial replication and subsequently develops the 
bacilli into the NRP form with low metabolic activity (Figure 1.5), which is believed 




Figure 1.5: The Wayne nonreplicating persistence model. Left of the figure shows 
a sealed tube with a magnetic stirrer, in which the bacilli are grown. Right of the 
figure displays a typical growth curve of mycobacteria under such conditions. The 
system is based on gradual, self-generated oxygen withdrawal due to mycobacterial 
growth in sealed stirred tubes. (Source: Dick, 2001)  
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In this system, the transition of mycobacteria to a state of NRP is characterized 
by three distinct growth stages. In the first stage, the dissolved oxygen concentration 
in the medium is high and the bacilli exhibit normal logarithmic growth.  
The second stage, termed NRP-1, occurs when the concentration of dissolved 
oxygen in the medium reaches 1%. The bacilli in this stage exhibit an abrupt 
discontinuation in DNA, and limited RNA synthesis. The bacilli also limit protein 
synthesis, and become resistant to several anti-TB drugs including INH and RIF 
(Stover et al, 2000; Wayne and Sramek, 1994). There is also an induction of genes 
that (i) allow utilization of alternative energy sources, (ii) stabilize and protect 
essential cellular products, and (iii) regulate downstream effector genes mediating 
adaptive responses (Rodrigue et al, 2006). Although bacilli in NRP-1 cease DNA 
synthesis, culture turbidity increases due to thickening of the bacterial cell wall 
During the third and final stage, NRP-2, dissolved oxygen concentrations drop 
below 0.06% in the culture medium, and bacilli switch from aerobic respiration to 
anaerobiosis. Bacilli in this state arrest growth at a uniform stage of the cell cycle and 
exhibit no further increase in cell turbidity. In addition, they exhibit sensitivity to 
metronidazole, a drug active against anaerobically growing organisms (Wayne and 
Sramek, 1994), and remain competent for growth reactivation following transfer into 
an oxygen-rich medium.  
While the NRP model cannot approximate the influence of the host’s immune 
system, it may explain some characteristics observed during persistent infection of 
tubercle bacilli in humans. Mycobacteria exposed to hypoxia in vitro stop replication 
but can remain viable and virulent for years (Wayne and Sohaskey, 2001). The model 
has also led to the discovery of a dormancy-induced transcriptional regulator (DosR; 
see Section 1.2.6.1), which is required for the mycobacteria to adapt for survival 
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during periods of oxygen limitation (Boon and Dick, 2002; Voskuil et al, 2003). 
Similarly, using this hypoxic system, factors such as a homolog of α-crystallin 
proteins (Yuan et al, 1998) and isocitrate lyases (Munoz-Elias and McKinney, 2005) 
are also found and observed to be associated with the Mtb persistence in macrophages 
and/or mice. Taken together, this in vitro system may represent a useful model to 
better understand the essential processes in Mtb during dormancy and latent infection.  
Notably, the dormancy response (physiology and expression of specific 
dormancy-specific markers) of the closely related but attenuated M. bovis BCG is 
demonstrated to be virtually identical to that of virulent Mtb (Lim et al, 1999). In 
view of this, M. bovis BCG can be considered as a model organism to study the 
physiology of the tubercle pathogen in NRP state. 
 
1.2.6 Mycobacterial genes required for persistent infection 
The ability of Mtb to undergo persistence requires the coordinated expression 
of numerous bacterial virulence determinants at specific times during infection. The 
identification of genes specifically utilized by the tubercle bacilli during periods of 
persistence is of particular interest because they may (i) define host conditions 
encountered by the pathogen during latent infection, (ii) allow the development of 
novel antibiotics that could target bacilli during latent stages, and (iii) provide 
alternative strategies for the development of rationally attenuated Mtb vaccines that 
are safer and more efficacious than the current BCG vaccine. To date, a handful of 
genes have been implicated in persistent infection by Mtb (Honer zu Bentrup and 
Russell, 2001). A “master controller” of these genes has been identified as the 
Dormancy Survival Regulator (DosR; also called DevR, Rv3133c). 
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1.2.6.1 The dormancy regulon: DosR-DosS/DosT response regulator 
The set of genes whose expression is controlled by the DosR-DosS/DosT two 
component response regulator (Roberts et al, 2004; Voskuil et al, 2003) is often 
known as the “dormancy regulon”. It is implicated in the mycobacterial dormancy 
response, and widely considered essential for TB latency. Consequently, the DosR 
transcriptional response has become one of the best characterized signal transduction 
systems in mycobacteria. The 48-gene regulon is controlled by the transcription factor 
DosR, which binds to a consensus DNA sequence to induce the transcription of the 
DosR regulon genes (Florczyk et al, 2003; Park et al, 2003), following 
phosphorylation by one of two cognate histidine sensor kinases, namely DosS or 
DosT (Roberts et al, 2004; Saini et al, 2004). The genes contained within the DosR 
regulon include those involved in the anaerobic respiration and lipid metabolism 
(Park et al, 2003; Sherman et al, 2001).  
Nearly all the genes initially induced by hypoxia require DosR for their 
induction (Park et al, 2003; Sherman et al, 2001), and mutants deleted of this 
transcription factor are impaired for survival under hypoxia (Boon and Dick, 2002). 
Other studies have shown that this dormancy regulon is coordinately regulated in 
response to treatment with nitric oxide (Voskuil et al, 2003), carbon monoxide 
(Kumar et al, 2008; Shiloh et al, 2008), or acidic pH (Rohde et al, 2007). These 
environmental conditions are likely to be encountered during latency in humans and 
possibly even contribute to the development of latent TB bacilli within the 
granulomatous lesions of the human lung (Zahrt, 2003). Furthermore, the DosR-
dependent transcriptional program is also induced following infection of macrophages 
(Schnappinger et al, 2003), mice (Karakousis et al, 2004; Shi et al, 2003) and guinea 
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pigs (Sharma et al, 2006), highlighting the importance of this dormancy regulon 
during the pathogenesis of TB. 
Members of the W-Beijing family of Mtb strains are reported to be associated 
with extensive morbidity and mortality worldwide (Bifani et al, 2002; Glynn et al, 
2002). Interestingly, it was observed that the DosR regulon is constitutively expressed 
in these hypervirulent strains (Reed et al, 2007). The upregulation of the dormancy 
regulon in W-Beijing Mtb strains is postulated to confer an adaptive advantage for 
their survival and growth in hypoxic environment thought to predominate in vivo 
during infection, and thus be related to the strength of epidemiological spread by this 
lineage (Reed et al, 2007). 
 
1.2.7 Lipids as nutrient source during dormancy 
Nutrient limitation is one of the major host stress-factors that is thought to be 
encountered by the tubercle bacilli in vivo during latent infection (Zahrt, 2003). 
However, the nutrient source required for the pathogenic mycobacteria to survive 
during latent infection remains elusive.  
Lipids have long been thought to play key roles in the pathogenesis of 
mycobacteria. In Mtb, 30% of the genome is devoted to lipid synthesis or metabolism 
(Cole et al, 1998). For more than half a century, it was observed that fatty acids (FAs) 
rather than carbohydrates were required to stimulate respiration of Mtb if the bacteria 
were isolated from mouse lungs instead of liquid cultures (Bloch and Segal, 1956). It 
was furthermore shown that the tubercle bacilli depend on the glyoxylate cycle for 
survival in mice (McKinney et al, 2000; Munoz-Elias and McKinney, 2005). 
Collectively, these findings indicate that mycobacteria utilize lipids, specifically FAs 
as the main carbon source during infection. However, the origin and the nature of the 
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storage form of FAs remains unclear (Gomez and McKinney, 2004; Russell, 2003). 
Of note, an increasing amount of evidence has suggested that triacylglycerols (TGs), a 
class of neutral lipids, are likely to be this source of FAs during periods of metabolic 
stress (discussed in the Section 1.3).  
Interestingly, a critical link between neutral lipid-storage accumulation and 
development of phenotypic drug-resistance in Mtb has been established. It is thus 
hypothesized that factors involved in the biosynthesis or breakdown of TGs might be 
appropriate targets for novel drugs that can eliminate Mtb during latency and 




1.3 Triacylglycerol Metabolism 
1.3.1 Triacylglycerols (TGs) and its properties 
TGs are non-polar, water-insoluble triesters of glycerol with FAs. These 
neutral lipids are convenient storage compounds for carbon and energy because they 
are oxidized less, and possess a higher calorific value than carbohydrates and proteins, 
yielding significantly more energy upon β-oxidation (Stryer, 1995). Many eukaryotic 
organisms synthesize and store TGs as reserve compounds as an integral part of their 
metabolism. Essentially, TG biosynthesis is important for the germination of plant 
seeds (Murphy, 1993), and is involved in the regulation of fat storage in mammalian 
adipocytes (Murphy and Vance, 1999). Eukaryotic microorganisms such as yeast also 
frequently accumulate TGs, mostly during exposure to environmental stress (Leber et 
al, 1994; Murphy, 1990). Buildup of neutral lipids in bacteria is, however, rarely 
reported except for Gram-negative Acinetobacter calcoaceticus (Fixter et al, 1986), 
and Gram-positive actinomycetes family. This latter group includes Mycobacterium 
(Anuchin et al, 2009; Daniel et al, 2004; Garton et al, 2002; Kremer et al, 2005), 
Streptomyces (Olukoshi and Packter, 1994), Rhodococcus (Alvarez et al, 2000) and 
Nocardia (Alvarez and Steinbuchel, 2002).  
 
1.3.2 Biosynthesis of TGs 
The glycerol phosphate (also known as Kennedy) pathway (Kennedy, 1957) 
and the monoacylglycerol (MG) pathway are the two major pathways in TG 
biosynthesis (Figure 1.6). Both pathways use fatty acyl-CoAs, the “activated” forms 
of FA synthesized by intracellular acyl-CoA synthases, as acyl donors (Coleman et al, 
2002). The glycerol phosphate pathway is present in most cells. In contrast, the MG 
pathway is found only in specific cell types, such as enterocytes, hepatocytes, and 
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adipocytes, where it may participate in the re-esterification of hydrolyzed TG (Xia et 
al, 1993).  
 
1.3.2.1 Glycerol phosphate pathway 
This pathway is largely identified by Kennedy and his coworkers in the 1950s. 
Biosynthesis of TG involves the formation of phosphatidic acid (PA) and 
diacylglycerol (DG), the two key intermediates of lipid metabolism.  
PA can either be synthesized de novo from the acylation of lyso-phosphatidic 
acid in a reaction catalyzed by acylglycerol-phosphate acyltransferase (AGPAT), or 
generated from diacylglycerol by diacylglycerol kinase (Martelli et al, 2002) (Figure 
1.6). Notably, generation of PA is a committed step in the glycerolipid biosynthesis, 
comprising the initial steps in other various phospholipids, namely, cardiolipin, 
phosphatidylinositol, and phosphatidylglycerol formation (Coleman et al, 2000).  
For TG biosynthesis, dephosphorylation of PA by a phosphatidate phosphatase 
yields DG, which is also formed from TG by TG lipases (Figure 1.6). DG is a 
precursor for major phospholipids (phosphatidylcholine, phosphatidylethanolamine 
and phosphatidylserine), and therefore a key intermediate in membrane lipid 
biosynthesis (Carman and Henry, 1999; Sorger and Daum, 2003). In addition, DG 
acts as a substrate for DG acyltransferases (DGATs), which convert DG to TG using 
different acyl donors. Importantly, this acylation of DG is regarded as the only 




Figure 1.6: Biosynthesis of TG and its metabolic pathways. The two pathway of 
TG anabolism are glycerol phosphate pathway and monoacylglycerol pathway, 
marked I and II respectively. Lipolysis pathway or TG catabolism is marked as III. 
Orange boxed enzymes: ACS, acyl CoA synthetase; AGPAT, acylglycerol-phosphate 
acyltransferase; DGAT, diacylglycerol acyltransferase; DGK, diacylglycerol kinase; 
GPAT, glycerol-phosphate acyltransferase; MGAT, monoacylglycerol 
acyltransferase; PAP, phosphatidic acid phosphatase. White boxed phospholipids: PC, 
phosphatidylcholine; PE, phosphatidylethanolamine; PG; phosphatidylglycerol; PI, 




1.3.3 Breakdown of TGs 
The breakdown or lipolysis of TG is carried out in three consecutive steps that 
are historically recognized to be facilitated by three enzymes: TG lipase, DG lipase 
and MG lipase respectively (Figure 1.6). Typically, TG lipase hydrolyzes FAs from 
carbon atoms 1 or 3 of TG. The resulting DGs are substrates for DG lipase. Finally 
the MGs are substrates for MG lipase. The net result of the action of these enzymes is 
three moles of free FA and one mole of glycerol. The free FAs are then activated to 
coenzyme A by thioesterification, so as to subsequently participate in biosynthetic or 
catabolic pathways (see Section 1.3.3.3). 
 
1.3.3.1 Characteristics of lipases 
All lipases whose structures have been solved display a similar 3-dimensional 
fold, called the α/β-hydrolase fold (Nardini and Dijkstra, 1999; Ollis et al, 1992), 
although their amino sequences may differ significantly. This fold consists of a core 
of eight mostly parallel β-sheets which are surrounded on both sides by α-helices 
(Figure 1.7). 
From a structural point of view, besides the substrate binding region, there is a 
mobile amphipatic structure of the protein, known as the “lid” which covers the 
catalytic active site of most lipases, and whose length and complexity depend on the 
enzyme (Secundo et al, 2006). Furthermore, an increasing body of evidence suggests 
that this structure is involved in modulating activity and selectivity of the lipases 
(Brocca et al, 2003; Dugi et al, 1995; Holmquist et al, 1995; Secundo et al, 2004). 
Taken together, the lid appears to play a very complex role in lipases activity, 
specificity and conformational stability. 
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Importantly, lipases are serine hydrolases, with a catalytic machinery 
consisting of a triad (Ser-His-Asp) (Brady et al, 1990; Derewenda and Derewenda, 
1991; Ollis et al, 1992; Wong and Schotz, 2002), and several oxyanion-stabilizing 
residues (Figure 1.7). Notably, lipases have a consensus active motif, Gly-X-Ser-X-
Gly. This important characteristic is attributed to the location of the serine residue in a 
tight γ-turn. Most turns are β-turn, whereby at least four Cα are involved in the bend. 
However, γ-turn is tighter where only three Cα are in the bend. Only the glycines are 
small enough to allow this sharp turn to form. 
Since the serine residue is crucial to the catalytic activity of lipases, inhibitors 
are designed to form an ester with the side chain hydroxyl group of the serine, hence 
rendering the enzyme non-functional. Lipase inhibitors include tetrahydrolipstatin 
(Hadvary et al, 1991), diethyl-p-nitrophenyl phosphate (E-600) (Gilham et al, 2003; 




Figure 1.7: Schematic representation of α/β-hydrolase fold and catalytic site of a 
typical lipase. Oxyanion: residues that stabilize the oxyanion. α-helices are shown as 
rectangles, β-sheets as arrows. Numbers denote the eight mostly parallel β-sheets. 
Ser-His-Asp residues belong to the catalytic triad. 
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1.3.3.2 Tetrahydrolipstatin: inhibitor of lipid metabolism 
Tetrahydrolipstatin (THL; also known as orlistat) is a white to off-white 
crystalline powder, which is a chemically synthesized derivative of lipstatin, a natural 
product of the fungus Streptomyces toxytricini (Weibel et al, 1987). It contains a N-
formyl-L-leucine ester side chain and a β-lactone ring structure incorporated into a 
hydrocarbon backbone (Figure 1.8). The β-lactone ring is essential for its lipase-








THL is a potent inhibitor of pancreatic and intestinal lipases (McNeely and 
Benfield, 1998). The drug is not systemically absorbed by humans, and is able to 
inhibit the absorption of approximately 30% of dietary TGs (Lucas and Kaplan-
Machlis, 2001). It binds covalently as an ester to the active-site serine 152 residue of 
pancreatic lipase, in a ratio of 1:1 (Hadvary et al, 1991; Luthi-Peng et al, 1992). 
Because of its high efficacy against lipases, THL is currently indicated as a treatment 
for obesity, defined as a body mass index (calculated as weight in kg/height in m2) 
greater than or equal to 30 kg/m2 (Lucas and Kaplan-Machlis, 2001).  
Besides being an irreversible inhibitor of pancreatic and gastric lipases, THL 
is also able to block the thioesterase domain of fatty acid synthase (FAS) activity 
(Pemble et al, 2007), thereby halting the progression of prostate tumors (Kridel et al, 
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2004) and breast cancer cells (Menendez et al, 2005). FAS is a critical multi-enzyme 
complex involved in the anabolic conversion of dietary carbohydrates to FAs in 
mammals (Chirala et al, 2001; Joshi et al, 1997; Tsukamoto et al, 1983).  
It is intriguing that THL also exhibits anti-mycobacterial activity, but with an 
unknown mechanism (Kremer et al, 2005). Surprisingly, none of the known 
components of FAS-I and II pathways in mycobacteria were identified as possible 
targets of THL (Kremer et al, 2005). However, it is demonstrated that THL partially 
affects the production of mycolic acid in mycobacteria (Kremer et al, 2005), and is 
able to inhibit an enzyme (Rv3802c) that is likely to be involved in this biosynthetic 
pathway (Parker et al, 2009). Of note, Rv3802c is a bi-functional enzyme containing 
both phospholipase C and thioesterase activities which are consistent with its role in 
mycolic acid biosynthesis as this pathway involves multiple ester and thioester bonds. 
Collectively, THL might utilize different modes of action related to lipid metabolism 
for eliminating tumor cells and mycobacteria. It is also, however, possible that THL 
may have other anti-growth mechanisms and thus remain to be elucidated. 
 
1.3.3.3 Activation of free fatty acids (FAs) 
Acyl-CoA synthetases (ACSs) are a family of enzymes that catalyze the 
thioesterification of free FAs with coenzymeA to form activated intermediates. This 
metabolic process is fundamental, and can be found in all organisms from Archaea to 
man (Watkins, 1997). The formation of fatty acyl-CoA allows a non-reactive FA to 
participate in diverse metabolic processes such as phospholipids and neutral lipids 
biosynthesis (Klein and Lipmann, 1953; Kornberg and Pricer, Jr., 1953), energy 
production via β-oxidation (Mahler et al, 1953), and protein acylation (Linder and 
Deschenes, 2003; Resh, 1999). 
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In eukaryotes, ACS enzymes can be identified by two characteristics amino 
acid sequence motifs, the AMP signature and the FACS signature. These two motifs 
are defined not only by sequence identities and similarities between well-known 
members of this enzyme family but also by extensive biochemical analyses of mutant 
alleles with unique phenotypes (Black et al, 1997; Weimar et al, 2002). Furthermore, 
ACSs in mammals are divided into five sub-families based on the chain length of their 
preferred acyl groups: ACS short-chain (ACSS), C2 to C4; medium-chain (ACSM), C4 
to C12; long-chain (ACSL), C12 to C20; bubblegum (ACSBG), C14 to C24; very-long-
chain, solute carrier family 27A, C18 to C26 (Soupene and Kuypers, 2008). 
 
1.3.4 Eukaryotes store TGs in the form of lipid droplets (LDs) 
In eukaryotes, TGs are stored within spherical lipid inclusions, commonly 
known as lipid bodies, lipid particles, or lipid droplets (LDs). A LD is made up of a 
hydrophobic core of neutral lipids (mostly TGs and steryl esters), enveloped by a 
membrane monolayer of phospholipids with a characteristic set of proteins embedded 
between (Zweytick et al, 2000). Recently, proteomic studies have identified these LD-
associated proteins from various eukaryotic cell lines and tissues such as baker’s yeast 
(Athenstaedt et al, 1999), Drosophila (Beller et al, 2006), murine adipocytes 3T3-L1 
(Brasaemle et al, 2004), human hepatocyte cell line HuH7 (Fujimoto et al, 2004), 
Chinese hamster ovary K2 cells (Liu et al, 2004), hepatoma cells expressing hepatitis 
C core protein (Sato et al, 2006), and leukocytes (Wan et al, 2007). In the LD-
associated proteome of a typical size of about 30-50 major components, two 
prominent groups of members have been identified. The first group is the PAT family 
of peripheral membrane proteins, named after the first identified members: perilipin, 
adipophilin, and tail-interacting protein of 47-kDa (TIP47), which serve structural and 
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regulatory purposes (Bickel et al, 2009). The other major group, are ACSs and lipases 
that act on TGs, and enzymes of sterol biogenesis (Athenstaedt et al, 1999; Brasaemle 
et al, 2004). 
 
1.3.5 Mammalian PAT family of LD-associated proteins 
The PAT family of LD-associated proteins includes five members in 
mammals: perilipin, adipophilin, TIP47, S3–12, and OXPAT (Bickel et al, 2009). All 
PAT proteins share sequence similarity and the ability to bind intracellular LDs, either 
constitutively or in response to metabolic stimuli, such as increased lipid flux into or 
out of lipid inclusions. The PAT family is evolutionarily ancient; family members are 
present in many animal species such as frogs (Chan et al, 1999), fruit flies (Gronke et 
al, 2003; Miura et al, 2002), and fungi and slime molds (Wang and St Leger, 2007). 
This conservation of the family is indicative of its importance in regulating 
intracellular neutral lipid stores. 
The best-characterized members of the PAT family are the perilipins, which 
are highly phosphorylated proteins localized on the surface of lipid inclusions of 
adipocytes and steroidogenic cells (Greenberg et al, 1991). They are involved in the 
biogenesis of LDs and their stabilization, by acting as shielding proteins that control 
both the storage and lipolysis of TGs (Souza et al, 1998; Tansey et al, 2003). After 
phosphorylation by cyclic AMP-activated protein kinase A, perilipins are released 
from the LDs (Egan et al, 1990), thereby enabling TG lipases to bind to the lipid core 
and hydrolyze the embedded TGs (Brasaemle et al, 2000). Perilipins are encoded by a 
single-copy gene in three different forms (A, B, and C) by alternative splicing of the 
respective mRNA, which is tissue-dependent (Greenberg et al, 1993; Lu et al, 2001). 
Perilipins A and B from adipocytes have molecular masses of 56-kDa and 46-kDa 
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respectively, both exhibiting a common N-terminal amino acid sequence, which is 
also very similar to the N-termini of adipophilin and TIP47 (Londos et al, 1999). 
Notably, the anchorage of perilipin A to LDs, is mediated by three hydrophobic 
regions in the central portion of the protein (Garcia et al, 2003).  
In contrast to the restricted occurrence of perilipins in adipocytes and 
steroidogenic cells, other PAT proteins (adipophilin and TIP47) are expressed in 
many tissues and cell types (Heid et al, 1998; Wolins et al, 2006). Previous studies 
have suggested that adipophilin promotes neutral lipid accumulation by limiting the 
interaction of lipases with the TGs within the droplets (Listenberger et al, 2007). 
When pre-adipocytes develop into mature adipocytes, nascent LDs are surrounded by 
adipophilin (Jiang and Serrero, 1992). Interestingly, adipophilin does not exhibit 
extended hydrophobic domains like the perilipins. For its trafficking to LDs, it is 
shown that both N- and C-terminal regions of the adipophilin are two independent 
domains that are important for localizing the protein to pre-existing TG inclusions 
(Nakamura and Fujimoto, 2003).  
Intriguingly, a study revealed that heterogeneously expressed mammalian LD-
associated PAT proteins (perilipin A, adipophilin, and TIP47) are targeted to the 
intracellular lipid storage of recombinant actinomycetes: R. opacus PD630 and M. 
smegmatis mc2155 (Hanisch et al, 2006). Moreover, a murine LD-associated TG 
lipase is also able to localize to the lipid inclusions of yeast (Kurat et al, 2006). Taken 
together, these findings indicate that LD-associated proteins may have a conserved 
targeting signal that allows them to be specifically translocated to the intracellular 
LDs independent of host organisms. However, it remains ambiguous whether this 
channeling signal exists in the form of hydrophobic sequences (Subramanian et al, 
2004) and/or structures (Ostermeyer et al, 2004).  
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1.3.6 Patatin-like proteins: a new family of lipolytic enzymes 
For many decades, hormone-sensitive lipase (HSL) has been considered as the 
only enzyme responsible for the hydrolysis of TG (Hollenberg et al, 1961; Vaughan et 
al, 1964). However, this concept of TG metabolism was challenged by some 
important observations: the non-obese phenotype of HSL knock-out mice (Osuga et 
al, 2000; Wang et al, 2001; Zimmermann et al, 2003), and the accumulation of DGs 
in their adipose tissues (Haemmerle et al, 2006). These data strongly suggest that 
there may be one or more additional lipases existing in the adipose tissue that 
preferentially hydrolyze the first ester bond of the TG molecule. 
In the same year, three groups independently reported an enzyme capable of 
hydrolyzing TG, named as adipose triglyceride lipase (ATGL) (Zimmermann et al, 
2004), desnutrin (Villena et al, 2004), or phospholipase A2ζ (Jenkins et al, 2004). 
This particular lipase exhibits high substrate specificity for TGs, and is associated 
with LDs (Zimmermann et al, 2004). It was demonstrated that both enzymes, ATGL 
and HSL, act in a concerted effort to ensure efficient TG hydrolysis without DG 
accumulation in adipocytes (Schweiger et al, 2006).  
ATGL contains a patatin domain (Pfam01734), originally identified in patatin, 
the major protein of potato tubers (Shewry, 2003), which shows acyl hydrolase 
activity on lipid substrates (Andrews et al, 1988). Patatin lacks a typical catalytic triad 
(Ser-His-Asp) found in most identified lipases. Instead, from its crystal structure, it 
contains a catalytic diad, consisting of serine and aspartate residues (Rydel et al, 
2003). Albeit the poorly conserved primary sequence of the patatin domain, many 
proteins harboring this domain are emerging as a new class of lipolytic enzymes (TG 
hydrolases, lysophospholipases, and retinol ester hydrolase) in mammals, which play 
a fundamental role in lipid remodeling and catabolism (Kienesberger et al, 2009).  
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There are several reports indicating ATGL orthologs exist in other organisms 
as well, such as Brummer lipase in Drosophila (Gronke et al, 2005); Tgl3 
(Athenstaedt and Daum, 2003); and Tgl4 (Kurat et al, 2006) lipases in baker’s yeast. 
These data highlighted a novel group of patatin domain-containing proteins which 
have the capacity to bind to LDs, and mobilize the FAs from stored fats. Taken 
together with the PAT family proteins, a correlation between the functional capacity 
of proteins and their subcellular localizations is established. However, a recent study 
showed that transcriptional repression of a major LD-associated protein in microalgae 
failed to show any effect on TG metabolism, suggesting that this paradigm may not be 
always true (Moellering and Benning, 2010).  
The discovery of ATGL orthologs in various eukaryotes may imply that this 
class of lipolytic enzymes could be functionally conserved in prokaryotic organisms 
as well. Of note, Mtb has eight predicted genes encoding patatin-like proteins with 
their functions and localizations undetermined (Banerji and Flieger, 2004). 
 
1.3.7 Occurrence of TG deposits in mycobacteria 
Previous investigations have indicated an important role of TGs stored in the 
form of intracellular LDs in mycobacteria. Evidently, the tubercle bacilli accumulates 
TGs under hypoxic, acidic, or nitric oxide-stressed conditions (Daniel et al, 2004; 
Sirakova et al, 2006). Enzymes involved in TG synthesis, DGATs, are also 
upregulated in hypoxia induced-dormant Mtb cultures (Daniel et al, 2004). Recently, 
an in vitro multiple-stress dormancy model of low oxygen, high carbon dioxide, 
limited nutrient and acidic pH was formulated to mimic the in vivo conditions that the 
pathogen may encounter in human granulomas. In this dormancy model, Mtb ceases 
replication, accumulates intracellular LDs and acquires antimicrobial resistance (Deb 
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et al, 2009). Furthermore, TG storage increases drastically in growing hypervirulent 
Mtb W-Beijing strains (Reed et al, 2007), as well as in growing M. kansasii from 
clinical isolates especially during the late logarithmic phase (Kremer et al, 2005), 
suggesting that this lipid may play a role in virulence. In addition, the number of Mtb 
cells containing LDs is directly correlated to the proportion of nonreplicating cells in 
sputum samples from TB patients, highlighting the significance of TG accumulation 
for NRP in vivo (Garton et al, 2002; Garton et al, 2008). In light of these findings, it is 
therefore proposed that TGs may confer a survival advantage for the nonreplicating 
bacilli in vivo combined with its pathogenicity.  
The occurrence of massive TG inclusions is not limited to the pathogenic 
mycobacteria only. When saprophytic M. smegmatis was cultivated for a prolonged 
period in nitrogen-limiting media, the cells gradually acquired a morphologically 
distinct ovoid shape, and were loaded with large LDs (Anuchin et al, 2009).  
Mobilization of FAs from TGs requires their hydrolysis. It was demonstrated 
that hypoxia-induced dormant Mtb utilize TG deposits upon nutrient starvation (Deb 
et al, 2006). Furthermore, resuscitation of the dormant ovoid M. smegmatis cells was 
accompanied by their transformation into the typical rod-shape cells with smaller LDs 
(Anuchin et al, 2009). Collectively, these findings indicate that TG accumulation and 
utilization represent important aspects of mycobacterial lipid metabolism during 
periods of dormancy and reactivation, respectively. More importantly, it also suggests 
that TG biosynthetic and metabolic enzymes may be appropriate targets for novel 
drugs that kill Mtb during latency and reactivation of TB.  
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1.3.8 Proposed roles of mycobacterial TG 
It has been suggested that TGs do not serve solely as an inert lipid depot, 
instead may play several key roles in the metabolism of lipid-accumulating bacteria 
(Murphy, 2001). Specifically, TGs could be a key factor that allows mycobacteria to 
cope with adverse environmental stresses often experienced in human bodies and soil, 
providing them with an adaptive advantage over other prokaryotes (Alvarez and 
Steinbuchel, 2002).  
Firstly, TGs could serve as carbon and energy sources for the mycobacteria 
during starvation periods that usually predominate in the environment. Besides having 
a higher calorific value than other storage compounds such as carbohydrate, TGs are 
also excellent reserve materials due to their extremely hydrophobic properties. This 
allows the bacilli to store large amount of energy without changing the osmolarity of 
the cytoplasm.  
The second proposed use of bacterial TGs is to maintain the bacterial cell 
membrane fluidity. Specifically, this neutral lipid may act as donor of FAs for 
phospholipid biosynthesis or as acceptor of unusual FAs, which may disturb the 
fluidity of cell membrane (Murphy, 1993). 
Thirdly, TGs could also function as a reductant sink to neutralize the reductive 
stress associated with the catabolism of host lipids during Mtb infection (Singh et al, 
2009). A regulatory protein WhiB3, controls the differential production of various 
lipids including TGs in response to the fluctuations in intracellular redox environment 
(Singh et al, 2009). This finding suggests that the pathogen may channel toxic 
reducing equivalents into TG biosynthesis in order to cope with the environmental 
stresses encountered during persistent infection. 
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Furthermore, albeit not reported in mycobacteria yet, TGs may also act as 
carbon source for the biosynthesis of antibiotics from acetyl-CoA or malonyl-CoA 
precursors, as exemplified in the Streptomyces genus (Olukoshi and Packter, 1994). 
 
1.3.9 TG metabolic enzymes in myocbacteria 
Despite the attention given to the roles of intracellular TGs in mycobacteria, 
the metabolic enzymes involved in the buildup and breakdown of this class of lipids 
are poorly understood. In the TG synthesis pathway, 15 members, annotated as TG 
synthase-encoding genes (tgs1-tgs15) have been identified in Mtb (Daniel et al, 
2004). They belong to a novel type of DGATs, the enzyme that catalyzes the final 
step of TG biosynthesis (see Section 1.3.2.1). Of which, tgs1 (Rv3130c), one of the 
genes of hypoxia-responsive dormancy regulon (Park et al, 2003; Sherman et al, 
2001), encodes the most active enzyme that preferentially incorporates C26:0 FA 
chains into TGs (Sirakova et al, 2006). This may also imply that other Tgs members 
could be responsible for the shorter FA substrates.  
In the TG degradation pathway, 24 predicted lipases have been identified, with 
LipY (Rv3097c) being the most active enzyme catalyzing the breakdown of TGs in a 
carbon-limiting condition (Deb et al, 2006). LipY belongs to a multigene PE (Pro-Glu 
motif) family with multiple copies of polymorphic GC-rich sequences (PGRS) at the 
carboxy-terminal portion (Cole et al, 1998). The C-terminal segment of this enzyme is 
homologous to the mammalian HSL characterized by the conserved GDSAG active-
site motif (Deb et al, 2006). Overexpression of LipY in saprophytic M. smegmatis 
significantly reduced TG deposits (Mishra et al, 2008). In addition, TG utilization was 
drastically decreased under nutrient-deprived conditions in a lipY-deficient mutant of 
Mtb. It was therefore proposed that LipY may be responsible for the utilization of 
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stored TGs during dormancy and reactivation of the pathogen. Interestingly, LipY is 
localized to the cell wall and cytoplasm of mycobacteria (Mishra et al, 2008). This 
leads to a hypothesis that LipY may act like mammalian HSL (Clifford et al, 2000), 
physically associating with the intracellular LDs and hydrolyzing the embedded TGs 
upon metabolic stimuli. However, whether LipY can translocate from the cell wall 
and cytoplasm to the lipid inclusions during TG breakdown, remains unknown.  
 The other characterized Mtb lipase that contains TG hydrolase activity is 
Rv0183 (Cotes et al, 2007). The genome annotation suggested that Rv0183 was a 
lysophospholipase, but it has been demonstrated that recombinant Rv0183 does not 
hydrolyse lysophospholipids. Rather, the preferred substrate of this lipase is MG, but 
it is also able to hydrolyse DG and TG weakly. Immunoblotting study of Rv0183 
showed that the enzyme was found in the culture medium and in the Mtb cell wall 
fraction. Therefore, it is possible that Rv0183 can be exported from the cell wall of 
Mtb to the extracellular medium (Cotes et al, 2007). Recent works revealed that Mtb 
persists within adipocytes (Neyrolles et al, 2006) and foamy macrophages (Peyron et 
al, 2008). These intracellular TG-rich environments may thus act as a vast nutrient 
reservoir for the pathogen during NRP state. It is possible that the tubercle bacilli can 
make use of exported lipases such as Rv0183 in the hydrolysis of host cell lipids 
during latent infection. In addition, the lipolytic function of extracellular Rv0183 may 
also play a physiological role after the reactivation step, when the pathogen is released 
from the granulomas, and disseminated throughout the human host. Yet, given the 
extracellular location of this lipase, it is unlikely that it has a role in intracellular TG 
hydrolysis in mycobacteria. Collectively, these findings indicate that the 
understanding of the molecular mechanism governing the intracellular TG 
metabolism in mycobacteria is still rather limited.  
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1.3.10 Mechanism of LD formation in prokaryotes 
Since TGs are packaged into intracellular LDs in mycobacteria during periods 
of metabolic stresses, it is important to know how these lipid inclusions are being 
formed. A general model of prokaryotic LD formation is proposed in Acinetobacter 
calcoaceticus and Rhodococcus opacus, which could be potentially different from the 
current models for eukaryotic LD biogenesis (Waltermann et al, 2005).  
In eukaryotes, it was suggested that the site of LD assembly is a specialized 
sub-domain in the endoplasmic reticulum (ER), where TG biosynthetic enzymes and 
related structural proteins are likely to be located. According to the widely accepted 
model, the TG inclusions are accumulated between the two phospholipid leaflets of 
the ER. Eventually, the mature LD will bud off from the ER, and surrounded by a 
phospholipid monolayer derived from the ER (Murphy and Vance, 1999). 
Similar to the formation of eukaryotic LDs at the ER membrane, bacterial TG 
synthesis is strictly associated with the plasma membrane, with one major difference: 
bacterial lipids are not synthesized between the leaflets of a phospholipid bilayer 
(Waltermann and Steinbuchel, 2005). Bacterial TG formation begins with the docking 
of DGATs to the plasma membrane, and subsequently small LDs are formed. These 
small LDs remain associated with the membrane-docked DGATs. In this phase of 
lipid accumulation, small LDs form an emulsive, oleogenous layer at the plasma 
membrane (Figure 1.9A). During prolonged lipid synthesis, small LDs leave the 
membrane-associated DGATs and conglomerate to membrane-bound pre-LDs (Figure 
1.9B and C). These pre-LDs reach distinct sizes before losing contact with the 
membrane and thereby releasing into the cytoplasm, as observed in M. smegmatis 
(Christensen et al, 1999), A. calcoaceticus and R. opacus (Waltermann et al, 2005). 
Inside the pre-LDs, small LDs coalesce with each other to form the homogenous lipid 
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core found in mature LD, which appear opaque in electron microscopy, whereas pre-
LDs exhibit a granulous internal structure (Figure 1.9D). Although it was not shown 
in detail, it is very likely that phospholipids associate in an early stage with 
membrane-bound small LDs, because mature cytoplasmic LDs are covered by 
phospholipids (Waltermann et al, 2005). This hypothesis (Figure 1.9E) is confirmed 
by experiments in artificial systems, whereby the formation of small LDs and pre-
LDs, and their final release from solid-phase-supported membranes are observed 
(Waltermann et al, 2005). 
It was further demonstrated that LD-associated DGATs were enzymatically 
active on isolated TG inclusions of A. calcoaceticus (Stoveken et al, 2005). This may 
indicate that lipid biosynthesis also occurs on intracellular LDs in situ. Despite this, it 
is questionable if the substrates (DGs and fatty-acyl CoAs) for TG biosynthesis can 
reach the LDs which are already released into the cytoplasm to a significant extent, 
since most bacterial enzymes for the biosynthesis of these precursors are typical 
membrane proteins (Coleman, 1990; Reiser and Somerville, 1997; Wilkison and Bell, 
1997). Furthermore, there is no explanation of how phospholipids could reach the 





Figure 1.9: Stages of the formation of TG inclusions in R. opacus PD630 and a 
generalized hypothetical model for the formation of lipid droplets (LDs) in 
prokaryotes. (A) Formation of an oleogenous layer from small LDs at the plasma 
membrane. (B) Pre-LDs formation through coalescence of small LDs. (C) Partly 
released pre-LDs. (D) Mature, cytoplasm-localized LDs. (E) Scheme. (Source: 
Waltermann and Steinbuchel, 2005) 
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1.4 Specific Aims of This Study 
The dynamics of TG inclusions in Mycobacterium and LD-associated 
metabolic enzymes constitute the primary focus behind this project. The importance 
of neutral lipid inclusions required at different growth states, especially during the 
reactivation of dormant bacilli remains unclear. Moreover, the current inventory of 
metabolic enzymes promoting the biosynthesis and degradation of TG deposits in 
mycobacteria is far from completion. Such anabolic and catabolic enzymes could be 
embedded in the mycobacterial LDs, as exemplified in the eukaryotic systems. 
Identification and functional characterization of LD-bound proteins can provide 
insights into key players in the machinery of TG metabolism, thereby filling the gaps 
in our current knowledge of lipid inclusions formation in prokaryotes. Subsequently, 
this pool of enzymes committed to TG metabolism can be validated as protein targets 
for further drug development. 
Our work in M. bovis BCG includes the following objectives: 
1. To study kinetics of TG metabolism during different growth phases. 
2. To investigate if catabolism of TGs is essential for the regrowth of 
mycobacteria during recovery from the hypoxic dormant state. 
3. To identify the protein components physically associated with the LDs of 
hypoxia-induced nongrowing bacilli.  
4. To characterize the functions of LD-associated proteins by phenotypic studies 
in gene-deleted, or gene-knock-in mutants. 
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Chapter 2 
Materials and Methods 
 
2.1 Bacterial strains and culture media 
M. bovis BCG Pasteur strain (ATCC 35734) and mutants were grown in 
Dubos broth (supplemented with 10% Dubos medium albumin, and 0.03% Tween 
80), or on Middlebrook 7H11 agar (supplemented with 10% oleic acid-dextrose-
albumin-catalase enrichment, and 0.5% glycerol) at 37 oC. E. coli Top10 strain 
(Invitrogen, Carlsbad, CA, USA) used for cloning was grown on Luria-Bertani 
medium. All media were purchased from Difco (Detroit, MI, USA).  
When required, antibiotics were added to the culture media at the following 
concentrations: kanamycin (Sigma-Alrich, St Louis, MO, USA), 50 μg/ml for E. coli 
or 25 μg/ml for M. bovis BCG; hygromycin (Roche, Mannheim, Germany), 150 
μg/ml for E. coli or 80 μg/ml for M. bovis BCG; ampicillin (Sigma-Alrich, St Louis, 
MO, USA), 100 μg/ml for E. coli. 
 
2.2 Mycobacterial cultures 
Culturing conditions including logarithmic, aerated stationary and hypoxia-
induced dormancy were adapted from established protocols (Boon et al, 2001). 
Inoculums used for starting the various cultures were prepared from growing cells. 
Essentially, aerobic M. bovis BCG cultures were grown in roller bottles with an initial 
optical density at 600nm (OD600) of 0.05. The logarithmic and aerated stationary 
cultures were rotated at 1 rpm for three and ten days, respectively. Mycobacterial 
cultures were subjected to slow withdrawal of oxygen as described (Wayne and 
Hayes, 1996) and grown with an initial OD600 of 0.005 in screw-cap test tubes [20 
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mm by 125 mm screw-cap flat bottom culture tubes (Wheaton, Millville, NJ, USA)] 
with a final volume of 17 ml each. The Wayne cultures were sealed by tightly 
screwing down solid caps with latex liners, and stirred gently at 170 rpm on magnetic 
stirring platforms for 20 days to allow the bacilli to enter into dormancy. Fresh air was 
re-introduced to hypoxic cultures through loosening of the caps for exit from 
dormancy. This exposure of air allows dormant bacilli to regrow.  
For isolating mycobacterial LDs, large quantity of nonreplicating M. bovis 
BCG had to be cultivated. Briefly, cultures (780 ml) with an initial OD600 of 0.005 
were expanded in glass bottles with a capacity of 1,000 ml (Duran, Wertheim, 
Germany), achieving an optimal headspace ratio of air volume to liquid volume as 
specified (Wayne and Hayes, 1996). The sealed cultures were stirred gently at 80 rpm 
for 20 days.  
Oxygen depletion in these cultures was monitored by the use of the oxygen 
indicator methylene blue as described previously (Wayne and Hayes, 1996). Growth 
and survival were monitored by enumeration of colony-forming units (CFU) on 
Middlebrook 7H11 agar after plating of appropriate dilutions.  
 
2.3 Exogenous FA treatment on mycobacterial cultures 
Fluorescent FA, 1-pyrenedecanoic acid (PDA) was acquired from Marker 
Gene Technologies Inc. (Eugene, OR, USA). PDA (excitation wavelength: 340 nm; 
emission wavelength: 377 nm) at a final concentration of 100 μM was supplemented 
to the Wayne dormancy cultures at the start of the experiments. Cells were harvested 
after 20 days of incubation for confocal microscopy analysis.  
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2.4 Lipase inhibitor treatment on mycobacterial cultures 
Tetrahydrolipstatin (THL, Sigma-Alrich, St. Louis, MO, USA) was added to 
mycobacterial cultures for a treatment of three days at a fixed concentration of 80 μM. 
Cells were harvested at the beginning and end of the treatment for analysis. A 




Figure 2.1: Schematic representation of M. bovis BCG culture conditions. A 
schematic diagram (not drawn to scale) illustrating the various mycobacterial culture 
conditions analyzed in this work. Cultures in logarithmic (log) phase, and aerated 
stationary phase were grown for three (d3A) and ten days (d10A) in oxygenated 
conditions, respectively. Cultures were also set up under hypoxic conditions (Wayne 
Model) for 20 days (d20) before exposure to air for three days (d3R, re-growth). 
Cultures were treated with tetrahydrolipstatin (THL, 80 μM) for three days as 
indicated by empty boxes. Solid and dotted lines represent oxygen-limited and 
oxygen-abundant environments, respectively.  
 
2.5 Lipid extraction 
Total lipids were extracted from M. bovis BCG cells or supernatant using a 
modified Bligh-Dyer method (Bligh and Dyer, 1959). Bacilli (4.0 X 108) were 
pelleted by centrifugation (3,000 g for 10 min), and washed twice with phosphate 
buffer saline containing 0.05% Tween 80 (PBST). Chloroform/methanol (6 ml, 2:1; 
v/v) was added to the cell pellet. Lipids were extracted at 4 oC for 24 hrs before 
introducing 4 ml of water to separate the phases by centrifugating at 3,000 g for 20 
min. Cell culture supernatants were used for lipid extraction of media. 
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Chloroform/methanol (2:1; v/v) was added to the supernatant in a ratio of 3:2 
followed by centrifugation at 3,000 g for 20 min. The lower organic phase was dried 
under a stream of nitrogen and stored at -20 oC until further analysis.  
 
2.6 Nile Red staining and confocal microscopy of mycobacteria 
Nile red (Invitrogen, Carlsbad, CA, USA) was used as according to 
established protocols (Greenspan et al, 1985). Briefly, 7.0 X 107 cells were washed 
twice with PBST before fixation with 4% paraformaldehyde for 10 min. Next, the 
cells were labeled with 10 μg/ml of Nile Red stain (excitation wavelength: 550 nm; 
emission wavelength: 650 nm) for 5 min and the excess dye was washed off. The cells 
were then mounted onto a slide in Fluorsave reagent (Calbiochem, Gibbstown, NJ, 
USA). The slides were observed by confocal microscopy using a Zeiss LSM 510 
Meta confocal microscope (Carl Zeiss, Thornwood, NY, USA) equipped with 543 
nm, 1 mW, HeNe laser as the excitation source. Images were viewed using EC Plan-
Neofluar 100x/1.30 Oil objective lens (Carl Zeiss, Thornwood, NY, USA) and 
captured using a photomultiplier tube with an LP615 nm filter.  
 
2.7 Thin layer chromatography (TLC) 
Dried lipid films were resuspended in 300 μl of chloroform/methanol 
(1:1; v/v). 10 μl of the resuspended lipid extracts were spotted onto 20 X 20 cm silica 
60 coated glass plates (Merck, Darmstadt, Germany). Plates were developed using 
hexane/diethyl ether/formic acid (45:5:1; v/v/v) as the solvent system. Iodine vapour 
was used to reversibly stain the lipids. Triolein (Sigma-Alrich, St. Louis, MO, USA) 
was used as a standard for TG. Defined amounts of triolein were spotted to establish 
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calibration curves using densitometry (Image J v1.37; National Institutes of Health, 
Bethesda, MD, USA). 
 
2.8 High performance liquid chromatography-mass spectrometry (LC-MS) of 
TGs 
A sensitive high-performance liquid chromatography-mass spectrometry (LC-
MS) method was developed to separate TGs from polar lipids, using an Agilent 
Zorbax Eclipse XDB-C18 column (4.6 mm X 150 mm). Analysis of TG was 
performed with an Agilent 1100 high-performance LC system coupled to a 4000 Q-
Trap mass spectrometer (Applied Biosystems, Foster City, CA, USA). Essentially, the 
high-performance LC conditions were (1) chloroform/methanol/0.1M NH4OAC 
(100:100:4, v/v/v) as mobile phase at a flow rate of 0.25 ml/min; (2) column 
temperature: 25 oC; (3) injection volume: 20 μl. MS was recorded under positive ESI 
modes. ESI conditions: turbo spray source voltage, 5000 volts; source temperature, 
250 oC; scan rate: 1000 amu/s; declustering potential: 30 volts; scan range: 300-1200 
Dalton. Dried lipid extracts were resuspended in the high-performance LC mobile 
phase. A total run time of 30 min was utilized to elute both polar lipids and nonpolar 
TG from the column, and the elution period of TG was averaged for comparison of 
TG profiles among mycobacteria in different growth conditions. The parameters of 




2.9 TG lipase assay 
Mycobacterial cells were washed twice with PBST, and resuspended in lipase 
buffer (100 mM glycine, 19 mM sodium deoxycholate, pH 9.5). Cell homogenates 
were prepared by subjecting the cells thrice to 1 min bead beating, with intervals of 3 
min on ice. The resulting cell homogenates were stored at -80 oC until analysis.  
Fluorescent lipase assay kits were purchased from Marker Gene Technologies, 
Inc. (Eugene, OR, USA). Measurement of TG lipase activity was performed 
according to the manufacturer’s protocol. Briefly, 50 μg of lysate were incubated with 
a fluorescent TG substrate, 1,2-dioleoyl-3-pyrenyldecanoyl-rac-glycerol (DPG). TG 
lipase activity was measured by monitoring the formation of PDA (excitation 
wavelength: 341 nm; emission wavelength: 377 nm) which is released from DPG 
upon enzymatic degradation, over a period of 30 min. TG lipase activity was 
determined as the increase of relative fluorescence unit (RFU) of PDA over a fixed 
period of time. A blank without any protein was used as a control.  
 
2.10 Isolation of intracellular lipid droplets from M. bovis BCG 
Hypoxia-induced nonreplicating mycobacterial cells were harvested by 
centrifugation (20 min, 6,000 g, 4 oC), and resuspended in Hypotonic Lysis Medium 
(HLM) containing 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, and protease inhibitor 
cocktail (Roche, Mannheim, Germany). After four-fold passage through a French 
pressure cell, crude extracts were obtained, and adjusted to 20% sucrose using a 60% 
sucrose stock solution in HLM. The density-adjusted fraction was then subjected to 
discontinuous sucrose gradient ultracentifugation as described previously (Brasaemle 
et al, 2004). Essentially, the discontinuous sucrose gradient consisted of equal volume 
of 0%, 5% and 20% (v/v) sucrose in HLM. The gradient was centrifuged for 30 min at 
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28,000 g at 4 oC. Floating lipid inclusions layer was collected and washed twice with 
HLM. Fraction containing cytosolic proteins was also collected by withdrawing the 
phase at the bottom of the tube. 
 
2.11 Delipidation of preparations and PAGE analysis 
All preparations were delipidated by extracting with chloroform/methanol 
(1:1; v/v). The inter-phase containing protein was washed with methanol once, air-
dried and solubilized in 10 mM Tris-HCl (pH 7.4) with 8 M urea for 1 hr.  
Proteins were quantified using BCA assay kit (Pierce, Rockford, IL, USA) as 
per manufacturer’s instructions. Equal amounts of proteins from each preparation 
were premixed with sample buffer and separated by 4-12% NuPAGE Bis-Tris gel 
electrophoresis in 2-(4-Morpholino)ethanesulfonic acid (MES) buffer system as 
recommended by the manufacturer (Invitrogen, Carlsbad, CA, USA), and silver-
stained using a glutaraldehyde-free system (Shevchenko et al, 1996).  
 
2.12 Mass spectrometric (MS) analysis and database searching 
Each silver-stained protein band was excised using clean blades. In-gel trypsin 
digestion was performed as described in an established protocol (Shevchenko et al, 
1996). Prior to analysis by matrix-assisted laser desorption/ionization-time of flight 
(MALDI-TOF) technique, the dried extracts were dissolved in 1 μl of matrix solution 
(5 mg/ml of α-cyano-4-hydroxycinnamic acid in 0.1% trifluoroacetic acid and 50% 
acetonitrile) following by spotting onto the MALDI target plate. MS analysis of 
generated peptide mixtures was performed by the ABI 4800 Proteomics Analyzer 
MALDI-TOF/TOF Mass Spectrometer (Applied Biosystems, Foster City, CA, USA) 
operating in a result-reflector positive MS and MS/MS mode.  
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 For peptide and protein identification, GPS ExplorerTM software Version 3.6 
(Applied Biosystems, Foster City, CA, USA) was used to create and search files with 
MASCOT search engine (version 2.1; Matrix Science). NCBI nonredundant protein 
sequence database was used for the search and was restricted to tryptic peptides. 
Peptide mass tolerance and fragment mass tolerance were set to 100 ppm and 0.2 Da 
respectively. Proteins were identified based on their scores, expectation values, 
sequence coverage and number of unique matching peptides. Protein scores greater 
than 81 (P < 0.05), low expectation values, larger sequence coverage and higher 
number of unique matching peptides correspond to confident identifications. 
Respective accession numbers and their functional information were obtained from 
BCGList (Institut Pasteur, 2006) and Tuberculist (Institut Pasteur, 2008) databases.  
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2.13 Generation of knock-out mutants and complemented strains of M. bovis 
BCG 
2.13.1 Disruption of mycobacterial genes 
 All disruptions in the knock-out strains were obtained using allelic exchange 
(homologous recombination) method as described (Bardarov et al, 2002). The general 
mechanism of allelic exchange is to construct a gene replacement cassette, followed 




Figure 2.2: Gene disruption using homologous recombination method. (A) 




2.13.2  Construction of knock-out (gene replacement) plasmids 
To generate an allelic exchange substrate for gene replacement, chromosomal 
sequences flanking the gene of interest were PCR-amplified from M. bovis BCG 
genomic DNA. Primers used in generating the various gene replacement constructs 
are listed in Table 2.1. The cloned fragments (without mutation) were subsequently 
introduced one after the other into the allelic exchange plasmid vector pYUB854, 
flanking the hygromycin resistance gene as a result. The final fragment to be 
introduced was excised from pGOAL17 plasmid at its PacI sites. This fragment 
containing lacZ and sacB marker genes was cloned into the different intermediate 
pYUB854 vectors to generate knock-out plasmids. This cloning procedure is 
schematically depicted in Figure 2.3. 
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Table 2.1: PCR primers to amplify 5’- and 3’-flanks of mycobacterial genes 
 
Gene Flank Sequence (5’-3’)a 
BCG1169c 5’b F: GACTTAAGGTAACGCCGTCCAGCCAGGC 
  R: ATCTAGACATTGGGTACATCAGGATGGTTCG 
 3’c F: GAAAGCTTAGCTGCGGGCCAGGCTGCA 
  R: GTACTAGTGCTACGCAACTGCGCGACTGC 
BCG1489c 5’ F: GTCTTAAGTTCCCGCCGACTCGAACGC 
  R: GCTCTAGATCAAGACTGGACGCAGCACACT 
 3’ F: GTAAGCTTCAAGCAGTTCGGCGAGGACC 
  R: GTACTAGTGGCCGTCGTAGCGGTTTCGA 
tgs1 (BCG3153c) 5’ F: GTCTTAAGTAGTGCCAGGATCGCGGC 
  R: GAGGTACCCGATAAGAAGGCTTCCTGATCG 
 3’ F: AGAAGCTTACTACGACGTGGTAGCAGATGCC 
  R: GCACTAGTACCGTGACGTTCCAACCCAT 
tgs2 (BCG3794c) 5’ F: GACTTAAGAATCCATTGTGGCGGTGACC 
  R: TAGGTACCACGCTCGGTGAACTCACGG 
 3’ F: AGAAGCTTATCTCGACTTCGGACTGGTCG 
  R: GCACTAGTACCATCTTCACCCTGTCCGATC 
a F, Forward; R, Reverse 
b Restriction sites of 5’ flank are underlined: F, AflII; R, XbaI or KpnI 





Figure 2.3. Cloning procedure of pYUB854 suicide delivery vector. GOI means 
gene of interest (BCG1169c, BCG1489c, tgs1 or tgs2). All the cloned fragments 
contained identical restriction sites.  
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2.13.3 Construction of complementation vector of mycobacterial genes 
  
For complementation, the coding sequences of the mycobacterial genes 
including approximately 400-bp upstream of the start codon were amplified from 
genomic DNA of M. bovis BCG using primers listed in Table 2.2. The fragments 
were then cloned into promoterless E. coli-Mycobacterium shuttle vector pMV306 
(Stover et al, 1991) to generate various complementation vectors.  
 
Table 2.2: Primers used for amplifying genes with their native promoters 
 
Gene Primer Pairs (5’-3’)a, b 
BCG1169c F: GATCTAGAACGTGGCGGTTATGCACGA 
 R: GTAAGCTTGGTCACTTCGCAGTCGCG 
BCG1489c F: GATCTAGAGCCGTCACGAAATTCTCGGT 
 R: GTAAGCTTGGCTTAGCCCAGAATCGGGA 
tgs1 (BCG3153c) F GATCTAGAGAACAGCTCCAGACTCGTCGG 
 R: GCAAGCTTTCACACAACCAGCGATAGCG 
tgs2 (BCG3794c) F: GATCTAGAAGTTCGACCAAATCGCCATC 
 R: GCAAGCTTTCTTTAGATCCCGACGGCCT 
a F, Forward; R, Reverse 
b Restriction sites are underlined: F, XbaI; R, HindIII 
 
2.13.4 Electroporation and selection of transformants 
M. bovis BCG cultures [wild-type (WT) and gene-null mutants] were grown to 
an OD600 of 0.6 in Dubos medium. 50 ml of mycobacterial cells were washed three 
times with equal volumes of 10% glycerol (Sigma-Alrich, St Louis, MO, USA) and 
0.05% Tween 80 (Sigma-Alrich, St Louis, MO, USA) to prepare for electroporation. 
All plasmids described in the previous sections were subjected to UV exposure at a 
rate of 70 J/cm2, and were introduced subsequently into competent bacterial cells at a 
concentration of >1 μg. Cuvettes with an electrode gap of 2 mm were used for 
carrying out electroporation at 2,500V in a Gene-Pulser XCell machine (Bio-Rad, 
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Hercules, CA, USA). Transformants carrying the knock-out plasmids (gene 
replacement cassettes) were first selected on 7H11 plates containing hygromycin and 
X-Gal. Colonies were observed after an incubation period of four weeks, inoculated 
and grown to a suitable turbidity for characterization. Deletion mutants were 
confirmed by Southern blotting (Annex 12). In gene-disrupted mutants, respective 
complementation plasmids were electroporated accordingly with the same protocol as 
described above. Transformants containing the complementation vector were selected 
on 7H11 plates containing both hygromycin and kanamycin.  
 
2.14 Mycobacterial genomic DNA isolation 
Mycobacterial cells from WT and gene-null strains were grown till stationary 
phase (OD600 1.2) in 50 ml Dubos medium. They were harvested by pelleting down at 
3000 g for 10 min. Each pellet was washed with 0.05% Tween 80 before resuspended 
in 600 μl Buffer 1 containing 3% SDS, 1 mM calcium chloride, 10 mM Tris-HCl, and 
100 mM sodium chloride. Cells were transferred to screw-cap tubes containing 0.1 
mm-diameter glass beads (BioSpec Products, Bartlesville, OK, USA), and heat-
inactivated at 85 oC for 30 min. After adding 20 μl of Proteinase-K (Invitrogen, 
Carlsbad, CA, USA), the bacilli were further incubated at 56 oC for 30 min. The cells 
were disrupted by three 1 min pulses using a bead beater, and unbroken bacteria and 
cell debris were pelleted by centrifugation. 0.5 M EDTA was added to each 
supernatant to a final concentration of 2 mM. An equal volume of 
phenol/chloroform/isoamylalcohol (49:49:2, v/v/v) was then added to each sample, 
and mixed for 1 min in a phase-lock tube (Eppendorf, Hamburg, Germany). The 
aqueous phase was extracted upon centrifugation at 16,000 g for 5 min. To the 
aqueous phase, a 0.1 volume of 3 M sodium acetate and 0.8 volume of isopropanol 
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were introduced for DNA precipitation. Each DNA pellet was obtained by 
centrifugation at 16,000 g for 15 min, and washed with 500 μl of 70% ethanol. The 
supernatants were removed and the remaining pellets were left to dry for 10 min. 
Finally, the precipitated DNA pellets were resuspended in 100 μl of TE buffer. 
Samples were stored at -20 oC for long-term storage.  
 
2.15 Southern blot hybridization 
2.15.1 Transfer of DNA from gel to membrane 
BamHI restriction enzyme (New England Biolabs, Ipswich, MA, USA) was 
added to 1 μg of genomic DNA isolated from WT and gene-deletion mutant strains of 
M. bovis BCG. Restriction digest was carried out at 37 °C for three hours and the 
DNA samples were fractionated side by side on a 1% agarose gel stained with 
ethidium bromide. Depurination of DNA was done by soaking the gel in several 
volumes of 0.2 N HCl until bromophenol blue turned yellow and xylene cyanol turned 
yellow/green. After rinsing with deionized water, the gel was soaked for 15 min at 
room temperature in several volumes of alkaline transfer buffer (0.4 N NaOH and 1 
M NaCl) with constant gentle agitation. The buffer was changed and soaking was 
allowed for a further 20 min with gentle agitation. For the transfer of DNA, a piece of 
charged nylon membrane was cut and placed on the surface of a dish of deionized 
water until it was wetted completely from beneath. Following which, the membrane 




2.15.2. Assembly of transfer apparatus 
While the DNA was denaturing, a piece of thick blotting paper was placed on 
a pedestal with its ends draped over the edges of the support. The large dish 
containing the pedestal was filled with alkaline transfer buffer until the level of the 
liquid reached almost to the top of the support. All air bubbles were smoothened out 
with a glass rod. The gel was removed after incubation and inverted such that its 
underside faced upwards. The soaked, charged nylon membrane was lowered gently 
onto the gel to prevent formation of bubbles which could interfere with proper 
transfer. A stack of paper towels was placed on the nylon membrane and weighed 
down with heavy weights. The transfer of DNA was carried out for 24 hrs before the 
whole apparatus was dismantled for the removal of the nylon membrane. Because 
alkaline transfer results in covalent attachment of DNA to positively charged nylon 
membranes, there is no need for fixation of the DNA to the membrane before 
hybridization. However, preceding hybridization of probes, the membrane had to be 
soaked in neutralization buffer (0.5 M Tris-HCl, pH 7.2 with 1 M NaCl) for 15 min at 
room temperature for neutralization, as well as to remove any pieces of agarose 
sticking to the membrane.  
 
2.15.3. Synthesis of DIG-labeled probes and hybridization 
Three separate probes were synthesized using the PCR Digoxigenin (DIG) 
Probe Synthesis Kit (Roche, Mannheim, Germany), using the primers as listed in 
Table 2.3 at a final concentration of 1 μM in the reaction mixture. Synthesis 
conditions were similar to the respective optimal primer annealing conditions during 
PCR amplification. A control using unlabeled dNTPs instead of DIG-labeled dNTPs 
was added alongside to check for successful synthesis of the probe. DIG-labeled 
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nucleotides in the template run slower in the gel than unlabeled DNA; a band that 
runs at a higher size would indicate the correct incorporation of DIG dNTPS. Once 
the probes were ready, they were denatured into single strands at 95 oC for 5 min and 
placed immediately on ice thereafter. For preparation of hybridization, the membrane 
was pre-soaked in a commercially available hybridization buffer, DIG Easy Hyb 
(Roche, Mannheim, Germany) for an hour at 37 oC. The buffer was discarded. Each 
probe was then added at the recommended concentration of 2 μl/ml in the 
hybridization solution and left to incubate overnight at 42 oC under gentle agitation. 
The box was sealed in parafilm to prevent evaporation of the hybridization buffer.  
 
Table 2.3: PCR primers to generate probes for Southern blot hybridization 
 
Gene Probe Sequence (5’-3’)a 
BCG1169c 3’b F: TTCCAGACGCTGCTCGCC 
  R: TGAGGTTGCGACGAAGCGT 
 intc F: ACGTGGTGATGCGATTCCAAC 
  R: AGCGTCAGCGCCGGATAGT 
BCG1489c 3’ F: TGCAGCAAGCCCTCAACGA 
  R: ATGAATGCGATCACGACATCG 
 int F: GGTGCATGGCCTGGACTCCT 
  R: GAACGGAAAGCCGAACGAGAT 
tgs1 (BCG3153c) 3’ F: GGCGATCAGTAAGCGGC 
  R: GGCCTTCGCGGTCTTCAGATA 
 int F: ACTTCGATCTTGGCCGTCATG 
  R: GTCAACGCCTCGCTTGGATT 
tgs2 (BCG3794c) 3’ F: TCGTCGCTGAAGGATCTGGAA 
  R: CTGACCAGCACCGACCTGATAG 
 int F: TCGACGCTGAAGCTGGCTC 
  R: ATGACGATGTTGAACGGTGGC 
Hyg cassette  hyg F: GAGAGCCTCGCGTCGGAGTC 
  R: GCAGTTGCACCAGGCTGTAG 
a F, Forward; R, Reverse 
b 3’, 3’-end of the gene of interest 
c int, sequence within the gene of interest 
 65
2.15.4. Immunological detection of DIG labeled probes 
The following day, a series of stringency washes was performed before probe 
detection: (1) 2x SSC + 0.5% SDS, 1 min; (2) 2x SSC + 0.1% SDS, 15 min; (3) 0.1x 
SSC + 0.1% SDS, 30 min and (4) 0.1x SSC, 2 min. SSC was prepared as a 10x stock 
solution, and contained two different components: sodium chloride NaCl and 
trisodium citrate dehydrate, adjusted to a final pH of 7.0.  
Subsequently, the membrane was treated in several buffers, which were 
available as a set of DIG Wash and Block Buffers (Roche, Mannheim, Germany). All 
solutions were adjusted accordingly by volume to their appropriate working 
concentrations. Followed by stringency washes, the membrane was first rinsed briefly 
in sufficient volumes of washing buffer. Next, 100 ml 1x blocking solution was 
incubated for 30 min to block unspecific binding sites before the introduction of α-
DIG-alkaline phosphatase conjugated antibodies. For the detection of hybridized 
probes, these secondary antibodies were diluted 1:5,000 (150 mU/ml) in blocking 
solution and added to the membrane for 30 min, room temperature under gentle 
agitation. The membrane was washed twice with washing buffer and equilibrated in 
detection buffer for 2 min. For color development, 1 ml of NBT/BCIP solution was 
added to 50 ml fresh detection buffer before applying to the nylon membranes. BCIP 
is the alkaline phosphatase-substrate which reacts further after dephosphorylation to 
give a dark-blue indigo-dye upon oxidation. NBT serves herein as the oxidant and 
also gives a dark-blue dye. It intensifies the color and thereby makes the detection 
more sensitive. The reaction was sequestered with deionised water when the desired 
intensities of the bands are achieved. Images of the membranes were captured on a 
scanner for record purposes.  
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2.15.5. Membrane stripping for re-hybridization of different probes 
Dimethylformamide (DMF) was heated in a hybridization chamber at 60 oC 
for at least 30 min. For stripping, the membrane was incubated in heated DMF under 
constant temperature until the blue precipitate was removed. Brief rinsing in double 
distilled water was carried out twice, followed by washing in 0.2 N NaOH + 0.1% 
SDS at 37 oC under gentle agitation. After equilibrating in 2x SSC, the membrane was 
pre-soaked in DIG Easy Hyb buffer to prepare for the next round of probing. 
  
2.16 Construction of comparative model structure  
The amino acid sequence of BCG1721 (length: 999 amino acids) was 
retrieved from BCGList Web server (Institut Pasteur, 2006). pDomThreader (Lobley 
et al, 2009) was used to identify domains that may be present in the sequence and 
thereafter align the predicted domains to the corresponding sequence segments of the 
X-ray crystal structures with resemblance to the BCG1721 protein in terms of 
secondary structure features. Based on the alignments generated by pDomThreader, a 
comparative model of the BCG1721 lipase domain was built using the X-ray crystal 
structure of a mammalian gastric lipase (PDB code: 1k8q) as the template. The 
pDomThreader-generated sequence alignment of the predicted lipase domain of 
BCG1721 with the template was used as input for MODELLER9v3 (Eswar et al, 
2007), which generated 3-D model structures of proteins by satisfaction of spatial 
restraints. For the model building procedure, default parameters included in the 
“automodel” class were used. A comparative three-dimensional model structure of the 
BCG1721 lipase domain was thus obtained. Quality of the model structure was 
assessed using PROCHECK (Laskowski et al, 1993) 
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2.17 Site-directed mutagenesis of the putative serine active site 
For construction of BCG1721(S150A), site-directed mutagenesis was 
performed. Intact BCG1721 in pCR2.1-TOPO vector was used as a template for the 
QuikChange II site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA) with the 
following primers, 5’-GCACTTCGTCGGGTATGCGCAGGGTGGCATGTTC-3’; 
and 5’-GAACATGCCACCCTGCGCATACCCGACGAAGTGC-3’ to convert the 
serine 150 coding TCG to GCG (alanine, underlined). The mutated gene clones were 
verified by automated DNA sequencing.  
 
2.18 Overexpression of BCG1721 and BCG1721(S150A) in M. bovis BCG 
For cloning of BCG1721 and BCG1721(S150A) in pMV262, the genes were 
amplified as BglII-HindIII fragments by PCR using pCR2.1-TOPO vectors containing 
BCG1721 or BCG1721(S150A) as templates and primers, 5’-GCAGATCTGTGGTG-
GATCTCAATTTTTCGAT-3’ and 5’-GCAAGCTTTCAAGCATTGCCGCGCCG-
3’. The PCR fragments were inserted into BamHI and HindIII sites of an E. coli-
Mycobacterium shuttle vector pMV262 (Stover et al, 1991) and placed under the 
control of the constitutive HSP60 promoter. The constructs were electroporated into 
WT M. bovis BCG, and transformants were selected on 7H11 plates with kanamycin. 
Overexpression of BCG1721 and BCG1721(S150A) in isolated colonies from the 
plates were assessed using quantitative reverse transcription-PCR (Figure 4.4D). 
 
2.19 RNA isolation and quantitative reverse transcription (RT)-PCR 
Mycobacterial cultures with an OD600 of 0.6-0.8 mixed with two volumes of 
RNA Protect bacteria reagent (QIAGEN, Venlo, Netherlands), incubated for 5 min at 
room temperature, and centrifuged at 3,000 g. Cell pellets were resuspended in 100 μl 
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of 8 mg/ml lysozyme, and transferred to screw-cap tubes containing 0.1 mm-diameter 
glass beads (BioSpec Products, Bartlesville, OK, USA). Cells were disrupted by three 
30 sec pulses using a bead beater, and unbroken bacteria and cell debris were pelleted 
by centrifugation. The supernatants were used to isolate total RNA with RNeasy mini 
kit (Qiagen, Venlo, Netherlands) according to the manufacturer’s protocol.  
DNase-treated RNA samples (1 μg) were reverse transcribed using random 
primers and iScript enzyme (Bio-Rad, Hercules, CA, USA) following the 
manufacturer’s instructions. Primer sequences were as followed: BCG1721 forward, 
5’-AATCGAGCGCCTGGTGGC-3’ and reverse, 5’-CATGTCCGCCGACATCA-
TCA-3’; and sigA forward, 5’-GCGACCAAAGCAAGCACGGC-3’ and reverse, 5’-
GTCGTAGTGTCCTGGGGTGC-3’. Quantitative RT-PCR reactions were carried out 
using iTaq SYBR Green supermix with ROX (Bio-Rad, Hercules, CA, USA), 0.3 μM 
primers, 100 ng of cDNA template and iQ5 Real-Time PCR Detection System (Bio-
Rad, Hercules, CA, USA) with standard conditions as recommended by the 
manufacturer. No-reverse transcriptase and no-template controls were included, and 
showed no PCR products. Relative quantification was performed using comparative 
threshold cycle (CT) method.  
 
2.20 Yeast strains and culture conditions  
The yeast strains used (Kurat et al, 2009) in this study were wild-type BY4742 
(MATα his3∆1 leu2∆0 lys2∆0 ura3∆0) and ∆-tgl4∆-tgl3 double mutant, YCK1158 
(MATα his3∆1 leu2∆0 lys2∆0 ura3∆0 YKR089c::kanMX4 YMR313c::kanMX4) 
obtained from Euroscarf library. Minimal medium (MM) with 2% glucose (Merck, 
Darmstadt, Germany) and 0.67% yeast nitrogen base (Difco, Detroit, MI, USA) was 
supplemented with required amino acids and bases. Media were buffered to pH 5.7 
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with MES. Yeast transformants carrying expression plasmids were grown on uracil-
free minimal SD medium at 30 oC. Expression of GST fusion proteins under control 
of the CUP1 promoter was induced by the addition of 0.5 mM copper sulfate to the 
medium. Expression of GFP fusions under control of the MET25 promoter was 
induced in the absence of methionine in the medium. 
 
2.21 Cloning and expression of BCG1721 and BCG1721(S150A) under control 
of the CUP1 promoter in yeast  
For overexpression of GST-BCG1721 and GST-BCG1721(S150A) under the 
control of a yeast CUP1 promoter, the genes were amplified as BglII-XhoI fragments 
using with the primers 5’-GCAGATCTGTGGTG-GATCTCAATTTTTCGAT-3’ and 
5’- GCCTCGAGTCAAGCATTGCCGCGCCG-3’. The fragments were then cloned 
into the BamHI and XhoI sites of pYEX-4T-1 (Clontech, Mountain View, CA, USA). 
 
2.22 Construction of mycobacterial genes-GFP episomal fusion for expression 
in yeast  
For localization studies in yeast, open reading frames of BCG1721, tgs1, tgs2, 
BCG1489c, BCG1169c and groES were amplified by PCR with primers as listed in 
Table 2.4, and cloned into pUG35 vectors, harboring a MET25 promoter and the GFP 
reading frame located at the 3’ end of the MCS (Niedenthal et al, 1996), for yielding 
C-terminal GFP fusions. Likewise, the BCG1721 was also cloned into pUG36 
plasmid, to produce N-terminal GFP fusion (Niedenthal et al, 1996). 
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Table 2.4: Primers used for expressing mycobacterial genes with GFP tag 
 
Gene Primer Pairs (5’-3’)a, b 
BCG1169c F: GCTCTAGAATGGCTACTGCACCGTATGGG 
 R: GCAAGCTTCTTCGCAGTCGCGCGGGTGAT 
BCG1489c F: GCTCTAGAATGAGCGAAACCGATAGCCCT 
 R: GCAAGCTTGCCCAGAATCGGGAAGCGGC 
tgs1 (BCG3153c) F: GCTCTAGAATGAATCACCTAACGACACTTGA 
 R: GCAAGCTTCACAACCAGCGATAGCGCTCC 
tgs2 (BCG3794c) F: GCTCTAGAATGGATCTGATGATGCCCAACG 
 R: GCAAGCTTGATCCCGACGGCCTGTTCCAG 
BCG1721 F: GCTCTAGAGTGGTGGATCTCAATTTTTCGAT 
 R: GCAAGCTTTCAAGCATTGCCGCGCCG 
groES (BCG3488c) F: GCTCTAGAATGGCGAAGGTGAACATCAAGC 
 R: GCAAGCTTCTTGGAAACGACGGCCAGCAC 
a F, Forward; R, Reverse 
b Restriction sites are underlined: F, XbaI; R, HindIII 
 
2.23 Lipid analyses in yeast  
For measurement of lipase activity in yeast, strain YCK1158, which is devoid 
of endogenous TG hydrolysis was transformed with pYEX-4T-1 plasmids harboring 
BCG1721, BCG1721(S150A), tgl4 (Kurat et al, 2009) or the empty vector. Cell 
cultures in 100 ml of MM were inoculated from 72 hrs pre-cultures to a cell density of 
2 X 107 cells/ml and cultivated by shaking at 30 oC. Within the first three hours, 
samples corresponding to 5 X 108 cells were withdrawn and the cells collected by 
centrifugation. Cell disruption, lipid extraction and analysis was performed as 
described previously (Zanghellini et al, 2008). Essentially, cells were mechanically 
broken and lipids were extracted by shaking with glass beads in chloroform/methanol 
(2:1, v/v). Total lipid extracts were separated on silica gel plates (Merck, Darmstadt, 
Germany) with the mobile phase petrol ether/diethylether/acetic acid (40:15:0.5, 
v/v/v), and stained at 120 oC for 15 min after submerging the plate in a solution 
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containing 3.2% H2SO4 and 0.5% MnCl2. TG was quantified against an appropriate 
mixture of TG standards. The obtained absolute values were normalized to the value 
at time=0.  
 
2.24 Immunoblot for checking gene expression of GST-fusions  
Total cell extracts were precipitated with 10% trichloroacetic acid and then 
solubilized in 0.1% SDS, 0.1% NaOH, and separated by one-dimensional SDS-
polyacrylamide gel electrophoresis using 5% stacking and 10% separating gels. 
Proteins were transferred to nitrocellulose membranes (Bio-Rad, Hercules, CA, USA) 
and incubated overnight in blocking solution containing 5% bovine serum albumin in 
TBST (10 mM Tris-HCl, 150 mM NaCl, 0.05% Tween 20, pH 8.0). After blotting, 
membranes were incubated for an hour with mouse anti-GST antibodies, washed three 
times in TBST, and incubated for an hour with anti-mouse peroxidase-conjugated 
antibody. Peroxidase reaction was performed according to the manufacturer’s 
instructions (Amersham Biosciences, Uppsala, Sweden), and detected on a Typhoon 
9400 scanner. Equal loading for the immunoblot was demonstrated by staining the gel 
with Coomassie-blue.  
 
2.25 Nile Red staining and confocal microscopy of yeast cells  
For localization studies in yeast, cells were transformed with episomal pUG35 
or pUG36 vectors, harboring the mycobacterial genes (BCG1721, tgs1, tgs2, 
BCG1489c, BCG1169c or groES)-GFP fusions or empty vector under control of the 
MET25 promoter. Transformants were harvested after 48 hrs of growth in selective 
MM, prior to microscopic inspection. Expression was induced on medium lacking 
methionine. Intracellular LDs were stained with the hydrophobic Nile Red dye 
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(Greenspan et al, 1985). Fluorescent signals of Nile Red were detected from 615 nm 
onwards, whereas GFP fluorescence, in the range between 505 and 530 nm. 
Microscopic analysis was performed using a Zeiss LSM 510 Meta confocal 
microscope (Carl Zeiss, Thornwood, NY, USA) equipped with 488 nm, 30 mW, 
argon laser as the excitation source. Images were captured as described in Section 2.6. 
 
2.26 Statistical analysis 
Data were obtained from at least three independent experiments performed in 
triplicate. Statistical significance was analyzed using Student’s t test; P < 0.05 was 
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3.1 Abstract 
Mycobacteria store triacylglycerols (TGs) under various stress conditions, 
such as hypoxia, exposure to nitric oxide, and acidic environments. These stress 
conditions are known to induce nonreplicating persistence in mycobacteria. The 
importance of TG accumulation and utilization during regrowth is not clearly 
understood. Here we specifically determined the levels of accumulated TG and TG 
lipase activity in Mycobacterium bovis bacillus Calmette-Guérin (BCG) in various 
different physiological states (logarithmic growth, aerated stationary phase, hypoxia-
induced dormancy, and regrowth from dormancy). We found extensive accumulation 
and degradation of TGs in the bacilli during entry into and exit from hypoxia-induced 
dormancy, respectively. These processes are accompanied by dynamic appearance 
and disappearance of intracellular TG lipid particles. The reduction in TG levels 
coincides with an increase in cellular TG lipase activity in the regrowing bacilli. 
Tetrahydrolipstatin, an inhibitor of TG lipases, reduces total lipase activity, prevents 
breakdown of TGs, and blocks the growth of mycobacteria upon resuscitation with 
air. Our results demonstrate that utilization of TGs is essential for the regrowth of 
mycobacteria during their exit from the hypoxic nonreplicating state. 
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3.2 Introduction 
Mycobacterium tuberculosis is the causative agent of tuberculosis (TB), one of 
the major infectious diseases, which affects one-third of the world’s population 
(World Health Organization, 2010). The majority of TB patients carry a latent 
infection. However, reactivation leading to active disease (Manabe and Bishai, 2000; 
Zhang, 2005) often occurs once the host defenses are weakened. During the latency 
period, mycobacteria are tolerant to many conventional antibiotics (Stover et al, 2000; 
Zhang, 2005), thus making eradication of TB challenging.  
In the human body, M. tuberculosis is believed to persist in lung lesions with 
hypoxic environments (Boshoff and Barry, III, 2005; Wayne and Sohaskey, 2001). 
Wayne and Hayes established an “in vitro dormancy model” in which mycobacterial 
cultures are subjected to gradual depletion of oxygen, which causes the obligate 
aerobic cells to exit the cell cycle and enter into a nonreplicating persistent state 
(Wayne and Hayes, 1996). The bacilli in the nonreplicating persistent state are 
phenotypically drug resistant. Recent efforts to explore the mechanisms which allow 
the tubercle bacilli to enter into dormancy and survive in the host for a long period of 
time suggest that fatty acids (FAs) could be an important source of energy during the 
persistent state (Bishai, 2000; Munoz-Elias and McKinney, 2005; Russell, 2003). In 
particular, triacylglycerols (TGs), a class of neutral lipids, are postulated to be a likely 
source of FAs (Daniel et al, 2004). TGs are an efficient form of energy reserves in 
many organisms during long-term survival.  
Recently, it was reported that tubercle bacilli in sputum from patients with TB 
contain lipid bodies (Garton et al, 2008). Moreover, TGs accumulate in hypervirulent 
W-Beijing strains of M. tuberculosis (Reed et al, 2007). It is interesting that TGs 
accumulate in these clinical strains of TB. However, no systematic study has been 
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carried out yet to investigate the accumulation and degradation of TG species under 
various physiological conditions in mycobacteria. Here we used M. bovis bacillus 
Calmette-Guérin (BCG) to study the kinetics of TG buildup and breakdown during 
different growth phases, including logarithmic growth, aerated stationary phase, 
hypoxia-induced dormancy (Wayne model), and regrowth from dormancy upon 
reaeration of hypoxic cultures. Utilizing tetrahydrolipstatin (THL) as a chemical 
probe, we showed that mobilization of TGs is essential for the regrowth of 





3.3.1 Accumulation and degradation of TG lipids under various physiological 
conditions  
 The kinetics of TG accumulation under various growth conditions 
(logarithmic, aerated stationary, hypoxia-induced dormancy, and regrowth) was 
analyzed using TLC (Figure 3.1A). During aerobic exponential growth, very little TG 
was present in the bacilli (4.9 ng per 106 cells), while no TG was detected in late 
stationary phase. On the other hand, TGs accumulated during hypoxia-induced 
dormancy, as has been reported previously for M. tuberculosis H37Rv (Daniel et al, 
2004). The pool of TGs was reduced dramatically once dormant cells underwent 
regrowth upon exposure to oxygen.  
 We next used LC-MS to determine the predominant TG species and their FA 
compositions. This sensitive approach revealed at least nine major species of TGs in 
M. bovis BCG (Table 3.1). The predominant species were TG with mass/charge (m/z) 
ratios of 875 and 905. FA compositions were confirmed using tandem MS (Table 
3.1). C16:1, C18:1, and C26:0 are the major TG species in dormant M. bovis BCG (Table 
3.1). The total TG intensities (sum for all nine TG species) as determined by LC-MS 
(Annex 1) correlated well with the results obtained by TLC (Figure 3.1A).  
 An attempt was made to monitor the presence of lipid droplets (consisting 
mainly of TGs) in M. bovis BCG in different physiological stages. In our studies, all 
of the dormant M. bovis BCG cells were positively stained with the Nile red dye, 
indicating the presence of TG lipid bodies. None of the bacilli under aerated 
conditions contained any Nile red-positive lipid droplets. These data thus further 
demonstrate the accumulation and disappearance of TGs in dormant and regrowing 




Figure 3.1: TG metabolism in M. bovis BCG during logarithmic, aerated 
stationary, hypoxia-induced dormancy, and regrowth phases. (A) TLC analysis of 
TGs in M. bovis BCG in different physiological states. Equal numbers of cells were 
harvested, and lipids were extracted using chloroform-methanol, separated on silica 
gel plates, and stained with iodine vapor. The values are the amounts of TGs as 
determined by densitometry using a triolein standard calibration curve. (B) TLC 
analysis of neutral lipids extracted from supernatants of M. bovis BCG under different 
growth conditions. Note that the disappearance of TGs in the cells during the 
regrowth phase is not due to export of the lipids into extracellular media. 
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Table 3.1: Predominant TG species which accumulated in M. bovis BCG during 
dormancy 
 
TG species (m/z) % FA1 FA2 FA3 
792 3.7 18:1 18:1 10:0 
  18:1 16:1 12:0 
  18:1 14:1 14:0 
  18:1 16:0 12:1 
     
818 6.0 18:1 18:1 12:1 
  18:1 16:1 14:2 
  16:1 16:1 16:1 
     
846 9.7 18:1 16:1 16:1 
  18:1 18:1 14:1 
     
875 27.0 18:1 18:1 16:1 
     
905 23.1 18:1 18:1 18:1 
     
932 10.8 18:1 14:1 24:0 
  18:1 16:1 22:0 
  18:1 12:1 26:0 
  18:1 18:1 20:0 
  16:1 16:1 24:0 
  16:1 14:1 26:0 
     
961 12.3 18:1 16:1 24:0 
  16:1 16:1 26:0 
  18:1 14:1 26:0 
  18:1 18:1 22:0 
  20:1 20:0 18:1 
  20:1 16:1 22:0 
  14:1 24:0 20:1 
     
991 5.9 18:1 18:1 24:0 
  18:1 16:1 26:0 
  18:1 14:0 20:1 
     
1017 1.5 18:1 18:1 26:0 
FA1-3: Fatty acid components of a TG molecule 
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3.3.2 M. bovis BCG incorporates exogenous FAs into its intracellular TG store  
We used LC-MS to examine the FA composition of TGs and found that m/z 
875 and m/z 905 ions represented major TG species under our culture conditions 
(Table 3.1). Both of these lipids contain mainly C18:1. Since oleic acid is present in the 
culture medium (Dubos and Tween 80), we postulate that the bacilli could use 
exogenous FAs as a substrate for TG synthesis. To validate this hypothesis, a 
fluorescent FA, PDA, was added to the Dubos media during hypoxia-induced 
dormancy. Confocal microscopy revealed that the lipid droplets were labeled with 
PDA (Figure 3.2A). Closer examination of LC-MS data also showed the appearance 
of various novel TG species when M. bovis BCG was treated with PDA (Figure 
3.2B). These TG species have m/z of 1022, 1051, 1081, and 1107, which correspond 
to addition of m/z 90 to endogenous m/z 932, 961, 991 and 1017 TG species, 
respectively. It is noteworthy that native m/z 818, 846, 875, and 905 TG species also 
have an m/z 90 addition in the PDA-treated bacilli. However, these species are less 
obvious in the mirror plot as the resulting m/z ions are m/z 908, 936, 965, and 995 
ions, which are almost identical to the endogenous TG species. Collectively, it was 
observed that PDA (molecular weight, 372.5) can competitively replace oleic acid 





Figure 3.2. Incorporation of exogenous fluorescent FA into intracellular stored 
TGs in M. bovis BCG during the hypoxia-induced dormancy phase. (A) Confocal 
images of dormant M. bovis BCG cells. Bacilli were treated with or without PDA 
(100 μM) for 20 days (Wayne model) before they were stained with Nile red dye. The 
panels (from top to bottom) show fluorescent images of Nile red signals (excitation 
wavelength, 550 nm; emission wavelength, 650 nm), PDA signals (excitation 
wavelength, 341 nm; emission wavelength, 377 nm), dual signals (overlay), and 
transmission microscope images of M. bovis BCG. Scale bar = 2 μm. The images are 
representative of the bacilli in at least 10 different microscopic fields. (B) Mirror plot 
showing LC-MS analysis of TG species in dormant M. bovis BCG cultured in the 
presence (top spectrum) or absence (bottom spectrum) of PDA (100 μM). Novel TG 
species corresponding to replacement of oleic acid (molecular weight, 282.5) with 
PDA (molecular weight, 372.5) are indicated. The TG species (m/z 829.9) which 
served as an internal standard (IS) was added during lipid extraction in order to 
normalize intensities for two different treatments. 
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3.3.3 Fate of TGs during regrowth from hypoxia-induced dormancy 
Since the size of intracellular TG pools decreases during the regrowth period, 
we investigated if the disappearance of TGs could be related to export of TGs into the 
extracellular media. Supernatants from hypoxic nongrowing and regrowing cells were 
analyzed to determine their TG contents. TLC profiles revealed that these 
supernatants contained hardly any detectable amounts of TGs (Figure 3.1B). Thus, if 
intact TG lipids were excluded from the cells, they would have appeared in the 
extracellular media. This suggested that TGs were not exported out of the cells during 
regrowth.  
If intracellular TG pools are hydrolyzed by enzymatic degradation, the activity 
of cellular TG lipases should increase accordingly. Thus, we measured total TG lipase 
activity under each growth condition using a fluorescent lipase assay. Indeed, the total 
TG lipase activity (Figure 3.3) is inversely correlated with the amount of TGs in M. 
bovis BCG (Figure 3.1A), indicating that the bacilli upregulate their lipase activities 




Figure 3.3: Reduction in cellular TG levels is correlated with increased lipase 
activity. Total TG lipase activities of mycobacterial extracts in the logarithmic, 
aerated stationary, hypoxia-induced dormant, and regrowth phases. Blank refers to a 
control incubated in the absence of mycobacterial proteins. The bars indicate means, 
and the error bars indicate standard deviations (n = 3). *, P < 0.05 for a comparison 
with the lipase activity in the logarithmic phase; **, P < 0.05 for a comparison with 
the lipase activity in the hypoxia-induced dormant phase. RFU, relative fluorescence 
units. 
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3.3.4 THL inhibits the TG metabolism of M. bovis BCG during regrowth from 
hypoxia-induced dormancy 
THL (commonly known as Orlistat; marketed as Xenical by Roche, Nutley, 
NJ) is approved for treating obesity. This drug acts as an irreversible inhibitor of 
pancreatic and gastric lipases (Borgstrom, 1988; Hadvary et al, 1991). THL has also 
been shown to have bactericidal effects on some mycobacteria (Kremer et al, 2005) 
and some activity against an extracellular lipase encoded by Rv0183 in M. 
tuberculosis (Cotes et al, 2007).  
To determine if THL has inhibitory activity against TG lipases in M. bovis 
BCG, we determined its inhibitory effect in total-cell lysates. The concentration of 
THL required to inhibit 50% of TG lipase activity was found to be approximately 40 
μM (Figure 3.4). In contrast, isoniazid (INH), a standard anti-TB drug, did not inhibit 
the lipase activity (Annex 2).  
The effect of THL on TG metabolism in different physiological states was also 
studied. Cultures of M. bovis BCG in different growth states were incubated with 
THL (80 μM) for 3 days. It was found that THL prevents the breakdown of TGs 
during exponential growth, hypoxic phases, and regrowth (Figure 3.5A and 3.5B). 
The dynamics of TG metabolism were correlated with the presence of Nile red-
positive intracellular lipid deposits (Figure 3.5C). Collectively, these results 






Figure 3.4: THL inhibits total TG lipase activity. Cell lysate of a regrowing 
mycobacterial culture was incubated with THL for 30 min prior to determination of 
the total TG lipase activity. The data are means ± standard deviations (n = 3). RFU, 




Figure 3.5: THL prevents the breakdown of TGs and lipid bodies during 
regrowth. (Full legend on next page) 
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Figure 3.5: THL prevents the breakdown of TGs and lipid bodies during 
regrowth. The cultures used contained bacilli in the logarithmic (d3A and d6A), 
aerated stationary (d10A and d13A), hypoxia-induced dormant (d20 and d23), and 
regrowth (d3R) phases (d, day; A, aeration; R, regrowth). All cultures were treated 
with or without THL (80 μM) for 3 days. (A) TLC analysis of TG levels in M. bovis 
BCG under different growth conditions and with different drug treatments. The values 
are the amounts of TGs as determined by densitometry. (B) LC-MS analysis of the 
total TG content in lipid extracts of M. bovis BCG under different conditions (n = 3). 
*, P < 0.05 for a comparison with the TG level in the regrowth phase without THL 
treatment. (C) Confocal images of M. bovis BCG cells stained with Nile red dye. The 
panels show transmission microscope images of M. bovis BCG integrated with a 
fluorescent signal (red). Scale bar = 2 μm. The percentages indicate the percentages of 
positively stained bacilli among 500 bacilli counted in at least 10 different 
microscopic fields. a.u., arbitrary units. 
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3.3.5 Regrowth of hypoxia-induced dormant M. bovis BCG is attenuated by 
THL treatment  
The effect of THL on the growth and survival of M. bovis BCG was 
determined by incubating BCG cells in various growth conditions in the presence or 
absence of THL. This drug had a mild effect on growth in the logarithmic phase 
(Figure 3.6). It had no inhibitory effect on aerated stationary cultures, which is 
consistent with the finding that TG metabolism seems to be minimal in this 
physiological state. Conversely, a significant effect on regrowing bacilli was 
observed, as the cells were unable to replicate when they were treated with the lipase 
inhibitor. Furthermore, THL also affected the survival of hypoxic dormant bacilli. 




Figure 3.6: THL inhibits regrowth of M. bovis BCG from hypoxia-induced 
dormancy. The numbers of CFU were determined under various growth conditions, 
and then appropriate dilutions of cells were plated. Note the approximately 10-fold 
reduction in the number of CFU upon THL treatment under regrowth and dormant 
conditions. The bars indicate the means, and the error bars indicate the standard 
deviations (n = 3). *, P < 0.05 for a comparison with the number of CFU in the 
regrowth phase without drug treatment. d, day; A, aeration; R, regrowth. 
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Our data demonstrated that THL was able to inhibit TG breakdown, thereby 
preventing the bacilli from regrowing after hypoxia-induced dormancy. However, it is 
possible that the lack of TG degradation could be just a side effect of the growth 
inhibition and not the primary reason for this effect. In order to address this issue, we 
used an effective antimycobacterial drug with a known mechanism of action as a 
reference control. INH inhibits the biosynthesis of FAs and mycolic acids very well 
(Kremer et al, 2005; Takayama et al, 1975). Moreover, based on work done with 
Mycobacterium kansasii, Kremer and colleagues concluded that INH and THL are not 
likely to share the same target(s) (Kremer et al, 2005). INH can inhibit growing and 
regrowing BCG very well (Annex 3). This is expected as INH affects cell wall 
synthesis that occurs only during the growth phase. When we examined TG profiles, 
we observed that INH does not prevent any TG hydrolysis during the regrowth phase 
(Annex 4). On the other hand, THL inhibits both cell growth and TG degradation 
during the regrowth phase. Therefore, our data demonstrated that the inhibition of TG 
breakdown significantly affects the regrowth of M. bovis BCG after a hypoxia-
induced nonreplicating phase. 
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3.4 Discussion 
The success of M. tuberculosis as a human pathogen lies in its capacity to 
remain dormant after an initial infection. The tubercle bacillus reactivates when the 
host immune defenses are compromised (Manabe and Bishai, 2000). This pathogen is 
believed to reside in granulomas during latency, and hypoxic environments within 
these lesions could act as stimuli for bacilli to change their metabolic states (Wayne 
and Sohaskey, 2001). In view of this, oxygen limitation was used as a means to 
induce tubercle bacilli into a state of dormancy (Wayne and Hayes, 1996). On the 
other hand, to compel the cells to resume replication, fresh air can be reintroduced 
into an hypoxic dormant mycobacterial culture. This method may mimic the 
reactivation of tubercle bacilli during reinfection in the host.  
TGs were shown to accumulate in M. tuberculosis H37Rv during hypoxia-
induced dormancy and after acidic and NO treatments (Daniel et al, 2004; Sirakova et 
al, 2006). Importantly, upon nutrient starvation, hypoxic dormant bacilli hydrolyze 
deposits of TGs (Deb et al, 2006), indicating that these lipids have an important role 
as a carbon reserve during periods of nongrowing persistence and reactivation. 
Furthermore, stored TG builds up in exponentially growing hypervirulent W-Beijing 
family strains (Reed et al, 2007). This suggests that TGs could provide a growth 
advantage to the W-Beijing family strains over other strains during latency since they 
have ready access to stored FAs. Intracellular TG particles are found in acid-fast 
stained bacilli derived from sputum of TB patients (Garton et al, 2002). These lipid 
particles are also proposed to be a biomarker for nonreplicating persistence (Garton et 
al, 2008) as a strong correlation between the intracellular TGs and nonreplicating 
dormancy has been established. However, in spite of all these findings, the 
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importance of TGs for survival or growth during different growth stages has not been 
clearly defined yet.  
Our results demonstrate that there is extensive accumulation and degradation 
of TGs in M. bovis BCG during entry into and exit from hypoxic conditions, 
respectively (Figure 3.1). Lipid droplets, the likely form of TGs inside bacilli, 
correlate with TG dynamics (Figure 3.5C), and such kinetics do not occur in aerobic 
conditions. The accumulation of TGs during dormancy has led workers to postulate 
that these neutral lipids are important for survival during latency and reactivation. 
Importantly, if TGs are utilized for energy consumption during regrowth, their 
hydrolysis would be required for release of FAs. Indeed, the reduction of intracellular 
TG particles during regrowth is accompanied by increased TG lipase activity (Figure 
3.3), suggesting that TGs are utilized as a source of energy or as a resource by the 
reactivating bacilli. Our findings thus indicate that TGs could act as a “reservoir” of 
FAs for utilization during regrowth from hypoxia-induced dormancy.  
Accumulation of TGs has been reported previously in dormant mycobacteria 
(Daniel et al, 2004; Garton et al, 2002; Garton et al, 2008; Sirakova et al, 2006). The 
exact identity of TG species, however, remains poorly characterized. TGS1 
(Rv3130c) seems to preferentially incorporate C26:0 into TGs (Sirakova et al, 2006), 
and it has been reported that the C26:0 FA is a major component of TGs under stress 
conditions (Sirakova et al, 2006). Using LC-MS, our study showed that m/z 875 and 
m/z 905 TG ions represent approximately 50% of all TG species during hypoxia-
induced dormancy (Table 3.1). The main FA species is C18:1, which is also esterified 
as Tween 80 found in the media. Furthermore, we found that the supplemented 
fluorescent FAs are able to compete with C18:1 for incorporation into the stored TG of 
dormant bacilli (Figure 3.2). These results thus indicate that M. bovis BCG is able to 
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take up exogenous FAs for the synthesis of intracellular TGs during hypoxia-induced 
dormancy. Our data are in line with the view that mycobacteria do require host lipids 
as a source of energy for survival during persistent infection (Bishai, 2000; Russell, 
2003). Pertinent to this, an extracellular lipase, Rv0183, has been characterized (Cotes 
et al, 2007), suggesting that the tubercle bacilli may hydrolyze lipids from the host 
tissue. Upon hydrolysis of host lipids, liberated FAs could be taken up by the bacilli 
and incorporated into intracellular TGs for storage as an energy or carbon source. 
Such a lipid degradation pathway might contribute to the viability of mycobacteria 
during infection, since these bacilli prefer to utilize FAs when they grow in vivo 
(Bloch and Segal, 1956; Segal and Bloch, 1957).  
Utilization of TGs as a carbon or energy source requires the activation of TG 
lipases. Genes encoding approximately 24 TG lipases have been predicted to be 
present in the genome of M. tuberculosis (Deb et al, 2006), and the lipY (Rv3097c) 
and Rv0183 products have been experimentally shown to possess TG lipase activity 
(Cotes et al, 2007; Deb et al, 2006). THL, an inhibitor of pancreatic lipases, reduced 
total lipase activity and prevented breakdown of TGs and regrowth of mycobacteria 
when they were resuscitated with oxygen (Figure 3.4 and 3.5). Intriguingly, dormant 
bacilli also have a lower survival rate when they are treated with a TG lipase inhibitor 
during hypoxia. Close examination showed that the TG content increased slightly 
after THL treatment (Figure 3.5). This increase in the TG pool could be attributed to 
prevention of TG hydrolysis during dormancy, which might be required for viability 
(Figure 3.6). This effect is minor compared to regrowth, which, at least in part, can be 
explained by the slower metabolism of dormant M. bovis BCG.  
In order to validate our pharmacological approach for probing the importance 
of TG utilization during the regrowth period, genetic complementation was carried 
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out. LipY has been reported to be an enzyme for utilization of stored TG in a nutrient-
deprived environment (Deb et al, 2006). Therefore, we knocked out lipY (BCG3122c) 
in M. bovis BCG in an attempt to generate a mutant deficient in TG hydrolysis. Our 
findings revealed that a lipY-deficient mutant has a significantly higher level of stored 
TG and decreased TG lipase activity compared to wild-type bacilli during the first day 
of the regrowth phase (Annex 5). The regrowth rate of the mutant was also affected as 
we observed lower numbers of CFU compared to the numbers of wild-type CFU 
(Annex 6). The lipY-deficient mutant exhibited a more pronounced phenotype only 
during the initial regrowth period, and this indicates that there may be other lipases 
that contribute to the degradation and utilization of TG in M. bovis BCG (Deb et al, 
2006). From the observations described above, it is apparent that the utilization and 
degradation of TGs are essential for the bacilli to exit from hypoxia-induced 
dormancy.  
We observed that THL at a concentration of 80 μM was able to block 
regrowth of nonreplicating bacilli. However, the concentration that blocked 50% of 
TG lipase activity was 40 μM. Furthermore, a microarray analysis also showed that 
THL treatment induced upregulation of a few putative lipases in the tubercle bacilli 
(Waddell et al, 2004). It is thus conceivable that THL inhibits multiple lipases. These 
enzymes are likely to complement one another during metabolism as gene redundancy 
is common in tubercle bacilli.  
Although we obtained evidence that THL prevents regrowth of mycobacteria 
via inhibition of TG lipases, we cannot exclude the possibility that there are off-target 
effects. Indeed, THL inhibits a thioesterase encoded by Rv3802c, an enzyme involved 
in mycolic acid biosynthesis (Parker et al, 2009), and was also shown to inhibit FA 
synthase in tumor cells (Kridel et al, 2004). However, THL only partially inhibits 
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overall mycolic acid formation compared to a cell wall synthesis inhibitor, INH 
(Kremer et al, 2005). In addition, we did not observe major changes in overall levels 
of mycolic acids and phospholipids using LC-MS technology with THL-treated bacilli 
during regrowth (data not shown). Hence, we attribute inhibition of mycobacterial 
regrowth by THL to prevention of TG hydrolysis.  
In summary, this study shows that TG accumulation, maintenance, and 
hydrolysis occur as bacilli enter, remain in, and exit hypoxia-induced dormancy, 
respectively. At these stages, TG lipase activity is regulated to utilize TGs for cell 
survival. The bacteriostatic effect of THL on mycobacteria implies that enzymes 
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4.1 Abstract 
Mycobacteria store triacylglycerols (TGs) in the form of intracellular lipid 
droplets (LDs) during hypoxia-induced nonreplicating persistence. These bacteria are 
phenotypically drug-resistant and therefore are believed to be the cause for prolonged 
tuberculosis treatment. LDs are also associated with bacilli in tuberculosis patient 
sputum and hypervirulent strains. Although proteins bound to LDs are well 
characterized in eukaryotes, the identities and functions of such proteins have not 
been described in mycobacteria. Here, we have identified five proteins: Tgs1 
(BCG3153c), Tgs2 (BCG3794c), BCG1169c, BCG1489c, and BCG1721, which are 
exclusively associated with LDs purified from hypoxic nonreplicating Mycobacterium 
bovis bacillus Calmette-Guérin (BCG). Disruption of genes tgs1, tgs2, BCG1169c, 
and BCG1489c in M. bovis BCG revealed that they are indeed involved in TG 
metabolism. We also characterized BCG1721, an essential bi-functional enzyme 
capable of promoting buildup and hydrolysis of TGs, depending on the metabolic 
state. Nonreplicating mycobacteria overexpressing a BCG1721 construct with an 
inactive lipase domain displayed a phenotype of attenuated TG breakdown and 
regrowth upon resuscitation. In addition, by heterologous expression in baker’s yeast, 
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these mycobacterial proteins also co-localized with LDs and complemented a lipase-
deficient yeast strain, indicating that neutral lipid deposition and homeostasis in 
eukaryotic and prokaryotic microorganisms are functionally related. The 
demonstrated functional role of BCG1721 to support growth upon resuscitation makes 
this novel LD-associated factor a potential new target for therapeutic intervention.  
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4.2 Introduction 
Mycobacterium tuberculosis, the etiologic agent of tuberculosis (TB) infects 
more than one-third of the world population, resulting in two million deaths per year. 
The success of this pathogen hinges on its ability to enter into a nonreplicating 
persisting (NRP) state upon infecting the human host. In this state, the mycobacteria 
survive quiescently for decades (Wayne and Sohaskey, 2001) and reactivate 
opportunistically, such as during co-infection with human immunodeficiency virus, to 
cause disease (Corbett et al, 2003). However, metabolic processes and enzymes 
necessary for the tubercle bacilli to transit into and out of the dormant state are not 
well characterized yet. 
It is widely recognized that M. tuberculosis utilizes fatty acids (FAs) as a 
carbon source during persistent infection (Russell, 2003). Mycobacteria store FAs in 
the form of triacylglycerols (TGs) during dormancy (Daniel et al, 2004; Deb et al, 
2009) and in TB patient sputum (Garton et al, 2002; Garton et al, 2008). Moreover, a 
direct correlation between the buildup of TGs and phenotypic drug resistance in M. 
tuberculosis was established (Deb et al, 2009), highlighting the importance of these 
lipids during latency and pathogenicity. TG utilization occurs when M. tuberculosis is 
subjected to a nutrient-deprived environment (Deb et al, 2006) and when 
Mycobacterium bovis bacillus Calmette-Guérin (BCG) is resuscitated from a hypoxic, 
nongrowing state (Low et al, 2009), which underscores the important functional role 
of intracellular lipid storage during NRP and pathogen reactivation in the host.  
Despite the attention given to the roles of intracellular TGs in mycobacteria, 
the metabolic genes involved in the buildup and breakdown of TG are poorly 
understood. To date, four proteins, encoded by TG synthase-encoding genes (tgs1-
tgs4), have been shown to contain diacylglycerol acyltransferase activity, catalyzing 
 98
the final step of TG biosynthesis (Daniel et al, 2004). Among these, Tgs1 (Rv3130c) 
is the most active TG synthase and preferentially incorporates C26:0 FA chains into 
TGs (Sirakova et al, 2006). Based on sequence information, 24 putative lipases have 
been predicted to play a role in TG catabolism, with LipY (Rv3097c) being the most 
active TG-degrading enzyme under carbon-limiting conditions (Deb et al, 2006). 
However, the deletion of lipY in M. bovis BCG does not prevent the hydrolysis of 
intracellular neutral lipid inclusions during regrowth (Low et al, 2009), demonstrating 
that other lipases must exist. These findings indicate that the understanding of TG 
metabolism in mycobacteria is still rather limited.  
TGs are typically stored as cytoplasmic lipid droplets (LDs) in pro- and 
eukaryotes and have been extensively studied using classical biochemical and 
proteomics approaches in the latter (Athenstaedt et al, 1999; Bartz et al, 2007; Beller 
et al, 2006; Brasaemle et al, 2004; Fujimoto et al, 2004; Liu et al, 2004; Sato et al, 
2006; Wan et al, 2007). Although the mechanisms of prokaryotic LD formation are 
potentially different from those in eukaryotes (Waltermann et al, 2005), proteins 
associated with mammalian LDs can be localized to the bacterial LDs when expressed 
in this heterologous host (Hanisch et al, 2006). Moreover, a bacterial diacylglycerol 
acyltransferase is able to functionally complement a yeast mutant devoid of TG 
biosynthetic genes (Kalscheuer et al, 2004). To date, however, no proteins are known 
to be physically associated with bacterial LDs (Waltermann et al, 2005). 
Identification and characterization of these factors is expected to have a major impact 
on our understanding of TG homeostasis, LD biogenesis, and turnover in prokaryotic 
systems and processes, which are critical to cellular maintenance and survival.  
In this study, we have identified five novel proteins (BCG1169c, BCG1489c, 
Tgs1 (BCG3153c), Tgs2 (BCG3794c), and BCG1721) that are exclusively bound to 
 99
an LD-enriched fraction from hypoxic NRP M. bovis BCG. We show that these 
proteins are involved in the metabolism of TG and specifically characterize BCG1721 
as an essential and presumably bi-functional enzyme with lipase and potential long-
chain acyl-CoA synthase (ACSL) activities on a single polypeptide chain. The 
identification of LD-associated key proteins involved in TG metabolism provides new 
insights into the mechanisms of prokaryotic neutral lipid storage and may lead to 
novel targets for TB therapeutic intervention. 
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4.3 Results 
4.3.1 Identification of proteins in the LD-enriched fraction from hypoxic NRP 
M. bovis BCG 
An LD-enriched fraction from hypoxia-induced M. bovis BCG in the NRP 
state was isolated using sucrose gradient ultracentrifugation. TLC analysis showed 
that most of the TGs were located in the top fraction (Annex 7). The LD layer and 
also the total lysate and cytosolic fraction were delipidated, precipitated, and 
separated by SDS-PAGE to compare their protein patterns. The protein composition 
of the LD fraction was distinctly different from that of crude lysate and cytosolic 
preparations, suggesting significant enrichment of LD-specific proteins (Figure 4.1). 
All of the protein bands present in the LD fraction and the corresponding bands from 
other fractions were subjected to tryptic digestion, and the proteins were identified 
using MALDI-MS (Annex 8). Notably, band 4 of the LD fraction was thicker in 
comparison with other preparations, which is in line with the finding that it contained 
three protein hits instead of one (Annex 8). Protein hits such as S-adenoyl-L-
homocysteine hydrolase and elongation factor Tu were found in all three preparations, 
which is consistent with the view that the LD-enriched preparation may contain some 
contamination of highly abundant cytosolic proteins. We classified LD-associated 
proteins to be polypeptides that are found either exclusively or in higher amounts in 
the LD fraction, compared with the crude extract. Based on the above criteria, gene 
products of BCG1721, tgs1, tgs2, BCG1489c, BCG1169c, and hspX (α-crystallin; 
BCG2050c) belong to the LD proteome of M. bovis BCG. The identified 
mycobacterial LD-associated proteins and their known or putative functions are 
summarized in Table 4.1. Notably, the LD-associated proteins identified in M. bovis 




Figure 4.1: SDS-PAGE analysis of LD-associated proteins. The protein 
composition of the LDs (lane 3) was compared with that of total lysate (lane 1) and 
cytosolic fraction (lane 2). Equal amounts of proteins were loaded into each lane and 
silver-stained after separation by SDS-PAGE. The positions of molecular mass 
markers are noted on the left. The bands indicated on the right side (in each lane) 
were further subjected to tandem MS analysis.  
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1 BCG1721 BCG1721 Rv1683 107.4 [Long-chain acyl-CoA synthase & lipase] 
4 tgs1 BCG3153c Rv3130c 50.7 Triacylglycerol synthase 
4 tgs2 BCG3794c Rv3734c 49.3 Triacylglycerol synthase 
6 BCG1489c BCG1489c Rv1428c 29.9 [Acylglycerol-phosphate acyltransferase] 
7 BCG1169c BCG1169c Rv1109c 23.0 [Unknown] 
8 hspX; acr BCG2050c Rv2031c 16.2 Heat shock protein 
a. Accession number in BCGList database.  
b. Accession number in Tuberculist database.  
c. Functions are based on amino acid sequence similarity analysis and as annotated in 
Tuberculist database. Square brackets indicate hypothetical functions. 
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4.3.2 Mycobacterial LD-associated proteins localize to lipid particles in baker’s 
yeast 
Heterologous expression has been successfully used to study localization and 
enzymatic properties of lipid metabolizing enzymes. To determine the specificity of 
LD association of the mycobacterial proteins in a heterologous system, they were 
expressed as fusion proteins to the GFP tag in yeast. As revealed in Figure 4.2, 
BCG1721-GFP, Tgs1-GFP, Tgs2-GFP, BCG1489c-GFP, and BCG1169c-GFP 
localized exclusively to yeast LDs, as demonstrated by their co-localization with Nile 
red. On the other hand, GroES-GFP and GFP were residing in the cytosol (Figure 2, 
bottom two rows). Thus, BCG1721, Tgs1, Tgs2, BCG1489c, and BCG1169c also 
associate with LDs in a heterologous system, further demonstrating the conserved 
nature of LD targeting mechanisms. Ubiquitously localizing HspX (Cunningham and 
Spreadbury, 1998), which was also identified in the proteomic study, was not 
included in this localization analysis; instead, GroES was used as a negative control 
protein that was absent from the LD fraction in mycobacteria (Annex 8), and it also 
does not localize to yeast LDs (Figure 4.2). Furthermore, orthologs from M. 
tuberculosis H37Rv also co-localized with yeast LDs, thus confirming that these 
proteins are indeed associated with LDs, irrespective of the mycobacterial species 





Figure 4.2: Expressed mycobacterial lipid droplet-associated proteins fused with 
GFP localize to the neutral lipid storage in yeast. Cells expressing BCG1721-GFP, 
Tgs1-GFP, Tgs2-GFP, BCG1489c-GFP, BCG1169c-GFP, GroES-GFP, and GFP 
alone (empty pUG35 vector), respectively, were co-stained with lipophilic dye Nile 
red, revealing localization of the tagged protein to either lipid droplets or cytosol. All 
of the GFP fusion proteins were expressed under control of the MET25 promoter in 
yeast. The panels (from left to right) display fluorescent images of GFP signals, Nile 
red signals, dual signals (Merge), and transmission microscope (Trans) images of 
baker’s yeast. The scale bar is 5 μm. The images are representative of the cells in at 
least 50 different microscopic fields.  
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4.3.3 Mycobacterial LD-associated proteins regulate TG buildup 
The majority of LD-associated proteins has functions related to lipid 
metabolism (Athenstaedt et al, 1999; Bartz et al, 2007; Beller et al, 2006; Brasaemle 
et al, 2004; Fujimoto et al, 2004; Liu et al, 2004; Sato et al, 2006; Wan et al, 2007). 
To evaluate the role of the identified proteins in TG metabolism, we generated single 
gene deletion mutants of tgs1, tgs2, BCG1489c, and BCG1169c and their respective 
complemented strains in M. bovis BCG. Several attempts to disrupt gene BCG1721 
failed, suggesting that it encodes an essential activity (see below). The strains were 
grown under hypoxia-induced NRP conditions. Neutral lipids were extracted and 
analyzed by TLC. Densitometry showed that TG storage was moderately diminished 
in all gene deletion mutants, and it was fully restored in their complemented strains 
expressing the plasmid-borne wild type (WT) genes (Figure 4.3A). Liquid 
chromatography-tandem MS analysis of lipid extracts from ∆-tgs1 and ∆-BCG1169c 
mutants revealed that TG species containing very-long-chain FAs [C22, e.g. 
TG(60:1)] were more significantly affected than those with long-chain FAs [C12-
C22, e.g. TG(52:3)] in these strains (Figure 4.3B and Annex 9). In contrast, the ∆-tgs2 
and ∆-BCG1489c mutants displayed an overall reduction of all measured TG species 
(Figure 4.3B and Annex 9). These data demonstrate that the identified LD proteins 
indeed participate in TG homeostasis but are distinct with respect to their contribution 





Figure 4.3: Disruption of genes encoding LD-associated proteins reduces TG 
accumulation during hypoxia-induced nonreplicating state. (A) TLC analysis of 
TG levels in different mutants, ∆-tgs1, ∆-tgs2, ∆-BCG1169c, and ∆-BCG1489c in 
hypoxic nonreplicating phase. The lipids were extracted from equal amounts of cells 
using chloroform/methanol, separated on silica gel plates, and stained with iodine 
vapor. The values depict TG amounts as determined by densitometry using a triolein 
standard calibration curve. Arrows indicate the reduced amounts of TG band with 
very-long-chain FAs in the ∆-tgs1 and ∆-BCG1169c strains. ∆, genetically disrupted 
strain; C-∆, complemented strain. (B) LC-MS analysis of FAs in TG levels in 
different strains during hypoxia-induced nongrowing state. TG levels refer to the 
neutral lipid with long-chain FAs (52:3) or very-long-chain FAs (60:1). These species 
are relatively abundant and representative of TGs containing long-chain and very-
long-chain FAs. Black bar, WT; white bar, ∆ strain; gray bar, complemented strain. 
The full details are in Annex 9. The data are represented as the mean values ± 




4.3.4 BCG1721 promotes the biogenesis of TGs in mycobacteria 
Domain alignment analysis of BCG1721 indicated that the protein contains a 
lipase and an ACSL domain at the N- and C-terminal regions, respectively (Figure 
4.4A). Based on these observations, a comparative model structure of the lipase 
domain was computed (Eswar et al, 2007) using a mammalian TG lipase (Protein 
Data Bank code: 1k8q) as a template (Figure 4.4B). By superimposing these 
structures, the putative catalytic triad consisting of Ser150, Asp309, and His338 was 
deduced (Figure 4.4C). The model also indicates that the lipase domain contains a 
“lid” (Secundo et al, 2006) that may regulate access of the substrate to the active site 
(Figure 4.4B). To ascertain the putative lipase activity of BCG1721, serine 150 of the 
catalytic triad was mutated to an alanine residue (S150A) by site-directed 
mutagenesis. BCG1721 and BCG1721(S150A) were expressed as glutathione S-
transferase (GST) fusion proteins in a baker’s yeast, ∆-tgl3∆-tgl4 double mutant that 
is devoid of TG hydrolysis (Kurat et al, 2006) and tested for lipase activity. 
Transformed yeast mutants overexpressing BCG1721-GST or Tgl4-GST, the 
endogenous LD-associated lipase (Athenstaedt et al, 1999), indeed had reduced TG 
content as compared with ∆-tgl3∆-tgl4 mutants expressing BCG1721(S150A)-GST or 
GST alone (Annex 10). In agreement with its localization to yeast LDs, these data 
confirm that BCG1721 is indeed a TG lipase in vivo and that serine 150 is essential 
for catalysis. 
Because repeated efforts to generate a gene deletion mutant of BCG1721 
failed, indicating that the gene might be essential for growth (Sassetti et al, 2003), we 
attempted overexpression of the gene in M. bovis BCG to characterize its potential 
role in TG metabolism. BCG1721 and BCG1721(S150A) were cloned into plasmid 
pMV262 under a constitutive hsp60 promoter and introduced into M. bovis BCG to 
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generate strains pBCG1721 and pBCG1721(S150A), respectively. Quantitative 
reverse transcription-PCR indeed confirmed elevated levels of BCG1721 transcripts 
in both strains (Figure 4.4D).  
LD formation was assessed in vivo in logarithmically growing BCG WT and 
pBCG1721 or pBCG1721(S150A) mutant strains by confocal microscopy after 
staining with Nile red (Figure 4.4D). LD were absent from the WT, as expected under 
these experimental conditions of stimulated TG catabolism, but were observed in both 
pBCG1721 and pBCG1721(S150A). These data suggest that the putative ACSL, 
rather than the lipase function, of the gene might be dominant under this experimental 
condition (Figure 4.4D). Indeed, TLC and liquid chromatography-tandem MS 
analysis revealed complex qualitative and quantitative changes in TG levels (Figure 
4.4E-F and Annex 11); TGs containing long-chain FAs [e.g. TG(52:3)] were 
significantly enriched in both pBCG1721 and pBCG1721(S150A) strains; however, 
TGs with very-long-chain FAs [e.g. TG(60:1)] were significantly reduced only in 
pBCG1721 but not in pBCG1721(S150A), compared with the BCG WT (Figure 4.4F 
and Annex 11). These results demonstrate that BCG1721 is involved in both 





Figure 4.4: Overexpression of BCG1721 or BCG1721(S150A) leads to increased 
intracellular TG storage in growing mycobacteria. (Full legend on next page) 
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Figure 4.4: Overexpression of BCG1721 or BCG1721(S150A) leads to increased 
intracellular TG storage in growing mycobacteria. (A) Schematic representation of 
the BCG1721. The black box denotes the putative lipase domain; the white box 
denotes the putative ACSL (AMP-binding) domain. Putative domain boundaries are 
indicated by the respective residue numbers, based on pDomTHREADER results. (B) 
Superposition of the three-dimensional model of the lipase domain (blue color) with 
the x-ray crystal structure of a mammalian TG lipase (orange color; Protein Data 
Bank code: 1k8q). The backbone of the lid structure of both proteins is in tube mode, 
whereas the rest of the structures are in line mode. (C) Close-up view of the catalytic 
triad. Amino acids Ser150, Asp309, and His338 correspond to the putative catalytic triad 
of BCG1721, whereas Ser153, Asp324, and His353 belong to that of Protein Data Bank 
entry 1k8q. Note the well conserved spatial arrangement between the two sets of 
catalytic triads. (D) Confocal imaging of different mycobacterial strains stained with 
Nile red. The left panels show transmitted images of WT (top panels), pBCG1721 
(middle panels), and pBCG1721(S150A) (bottom panels) integrated with red 
fluorescent signal. The scale bar is 2 μm. The images are representative in at least 50 
different microscopic fields. The center panels represent the gene construct 
schematically. The right panels depict gene transcript abundance within RNA samples 
as analyzed by quantitative reverse transcription-PCR. BCG1721 transcript copy 
numbers were normalized against that of sigA. Rel. Abundance, relative abundance. 
(E) TLC analysis of TG levels in different mycobacterial strains. The values depict 
TG amounts as determined by densitometry. An arrow indicates the reduced amount 
of TG band with very-long-chain FAs in pBCG1721 strain as compared with that of 
pBCG1721(S150A) cultures. (F) LC-MS analysis of FAs in TG levels in different 
mycobacterial strains, WT, pBCG1721, and pBCG1721(S150A). Black bar, TG(52:3, 
long-chain FAs); white bar, TG(60:1, very-long-chain FAs). The full details are in 
Annex 11. The data are represented as mean values ± standard deviations (n = 3). *, P 




4.3.5 Overexpression of BCG1721(S150A) leads to reduced TG hydrolysis and 
cell viability during regrowth from NRP 
To investigate the physiological role of BCG1721 during hypoxic NRP and 
regrowth phases, cultures of WT, pBCG1721, or pBCG1721(S150A) were grown in 
the hypoxia-induced NRP model, before reactivation with oxygen (air). TLC analysis 
showed elevated levels of TGs in hypoxic NRP strain pBCG1721 and the 
pBCG1721(S150A) mutant as compared with the WT (Figure 4.5A). No TG 
hydrolase activity was observed in pBCG1721 during the NRP state (Figure 4.5B), 
suggesting that the lipase is likely to be inactive under this physiological condition. 
Whereas the TG content of WT dropped during exposure to oxygen, consistent with 
stimulated TG hydrolysis, overexpression of BCG1721(S150A) led to a marked 
reduction of TG breakdown during regrowth (Figure 4.5A). This observation suggests 
a dominant negative effect of the inactive lipase under this condition (Figure 4.5B). 
Because TGs are required for the regrowth of mycobacteria from hypoxic 
NRP (Low et al, 2009) and TG breakdown was attenuated in pBCG1721(S150A), we 
evaluated the viability of the strain during regrowth. Indeed, bacilli overexpressing 
BCG1721(S150A) showed significantly reduced regrowth compared with cells 
without plasmid or with an additional WT copy of BCG1721. These results further 
demonstrate that TG breakdown is required for the regrowth of M. bovis BCG from 





Figure 4.5: Mycobacteria overexpressing BCG1721(S150A) has attenuated TG 
hydrolysis rate and cell regrowth from hypoxia-induced nonreplicating state. 
Mycobacterial strains were cultured to hypoxic NRP state and reactivated with fresh 
air (regrowth). (A) TLC analysis of TG levels in WT, pBCG1721, and 
pBCG1721(S150A) strains during hypoxic NRP and regrowth states. The values 
depict TG amounts as determined by densitometry. Note that some TGs remained in 
the reactivated bacilli transformed with BCG1721(S150A) as compared with those 
cells overexpressing the bi-functional BCG1721. (B) Total TG lipase activity of 
mycobacterial extracts at hypoxic NRP and regrowth phases. (C) Enumeration of 
colony-forming units (CFU) of different strains during hypoxic NRP and regrowth 
conditions were determined. Black bar, hypoxic nonreplicating; white bar, regrowth. 
The data are represented as mean values ± standard deviations (n = 3). *, P < 0.05 
compared with those of WT at the hypoxia-induced NRP phase. 
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4.4 Discussion 
M. tuberculosis is known to accumulate LDs during NRP states such as 
hypoxia-induced dormancy (Garton et al, 2002; Garton et al, 2008). These bacilli are 
phenotypically drug-resistant (Deb et al, 2009), which is believed to be a cause for 
lengthy TB treatment and latent infection. Virulent W-Beijing family strains of M. 
tuberculosis also store up large amounts of TGs (Reed et al, 2007). Garton and 
coworkers (Garton et al, 2002; Garton et al, 2008) reported the presence of 
intracellular LDs in M. tuberculosis isolated from the sputum of TB patients, 
highlighting the importance of TGs during infection. Our earlier findings emphasized 
the role of LD formation and utilization during dormancy (NRP) and regrowth of M. 
bovis BCG (Low et al, 2009). To obtain functional insight into the role of TG 
metabolism in mycobacteria, we attempted the identification and characterization of 
proteins involved in this process, which would greatly assist in developing novel 
antibacterials to treat TB. Here we decipher the mycobacterial LD proteome and its 
role in lipid biosynthesis and metabolism. 
Our work identified five LD-associated proteins involved in TG metabolism, 
and their presumed positions in the TG metabolic pathway are indicated in Figure 4.6. 
The TG synthases, Tgs1 and Tgs2, which are orthologs of mammalian LD-associated 
diacylglycerol acyltransferase 2 (Cases et al, 2001; Kuerschner et al, 2008), are 
abundant proteins in the mycobacterial LD-enriched fraction, thus validating the 
isolation method. Moreover, given the substrate specificity for very-long-chain FAs, 
our results are consistent with the analyses obtained for Tgs1 (Sirakova et al, 2006). 
TG profiling of Tgs2-null mutant cells implied that Tgs2 may have a broader 




Figure 4.6: Schematic representation of LD-associated proteins in TG 
biosynthesis and breakdown in mycobacteria. This pathway is a brief overview of 
our findings, depicting the involvement of LD-associated proteins in the metabolism 
of TGs. AGPAT, acylglycerol-phosphate acyltransferase; DGAT, diacylglycerol 
acyltransferase; FA-CoA, fatty acyl-coenzyme A; GPAT, glycerol phosphate 
acyltransferase; PAP, phosphatidic acid phosphatase. 
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Identification of different distinct TG molecular species supports the concept 
that bacterial LDs are synthesized initially as small diacylglycerol acyltransferase-
associated pre-LDs, before coalescing to become mature LDs, as shown in 
Rhodococcus opacus and Acinetobacter calcoaceticus (Waltermann et al, 2005). In 
our analysis of LD-associated proteins, we have identified the putative 1-acylglycerol-
3-phosphate acyltransferase, BCG1489c. This enzyme catalyzes the formation of 
phosphatidic acid, which is an important precursor for the synthesis of diacylglycerol 
that is subsequently acylated to TG, by Tgs. In addition, or alternatively, BCG1489c 
may also function to generate phosphatidic acid as a precursor for the synthesis of 
phospholipids. Because deletion of the BCG1489c gene resulted in an overall 
reduction of TG levels, it rather suggests a more prominent role in providing 
precursors for TG synthesis, in mycobacteria. Interestingly, we did not detect any 
proteins with homologies to phosphatidic acid phosphatases to be associated with 
LDs; presumably such proteins, like their yeast and mammalian orthologs, are 
cytoplasmic and/or membrane-bound (Han et al, 2006; Lin and Carman, 1989). 
A novel, presumably bi-functional enzyme BCG1721 containing an N-
terminal lipase and a C-terminal ACSL domain was found to be associated with LDs. 
We demonstrate that this enzyme has TG lipase activity also in the heterologous yeast 
system and that this activity is abolished by a single point mutation (S150A) in the 
predicted catalytic consensus site (GXSXG). Moreover, the ACSL domain at the C 
terminus appears to promote the biosynthesis of TG and LD accumulation, in 
agreement with reports that ACSL orthologs in human myocytes (Garcia-Martinez et 
al, 2005) and HEK293 cells (Hatch et al, 2002) increase TG content rather than 
phospholipid production. 
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The twin functions of the protein allow us to postulate that, during reactivation 
from the hypoxic NRP state, BCG1721 is able to hydrolyze TGs via the lipase domain 
to yield nonesterified FAs, which are next derivatized to acyl-CoA with the help of 
the ACSL domain (FA activation). The final product, fatty acyl-CoA, may 
subsequently be used in a number of metabolic pathways such as β-oxidation (Mahler 
et al, 1953) or synthesis of phospholipids for membrane turnover (Klein and 
Lipmann, 1953) or diacylglycerol re-esterification to TG. In eukaryotes, ACSL and 
TG lipase domains have never been described on a single polypeptide, but rather both 
enzymes may indeed exist independently of each other on LDs (Athenstaedt et al, 
1999; Brasaemle et al, 2004). We found that the ACSL domain was active, 
independent of the lipase function of the protein, thus providing fatty acyl-CoA 
substrates for the Tgs-catalyzed reactions, specifically during the logarithmic phase 
and the hypoxia-induced NRP state. 
In the absence of active BCG1721 lipase (S150A mutant), TG breakdown was 
efficiently blocked in M. bovis BCG during regrowth. Consequently, the TG-loaded 
bacteria were unable to reactivate from the NRP state. This finding is consistent with 
our previous observation that utilization of TG is required for regrowth (Low et al, 
2009) and further highlights the importance of the intracellular TG pools in 
mycobacteria. Although the pBCG1721(S150A) mutant strain harbors a WT copy of 
the gene, the observed TG phenotype is presumably due to a dominant negative 
effect, as has previously been observed in the case of a kinase-dead mutant of PknG in 
M. bovis BCG (Walburger et al, 2004). 
The highly abundant LD-associated protein HspX, which is ubiquitously 
present in mycobacteria (Cunningham and Spreadbury, 1998), acts as a chaperone 
enhancing the stability of protein by preventing misfolding (Yuan et al, 1996). Similar 
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chaperone proteins were also identified on eukaryotic LDs (Athenstaedt et al, 1999; 
Beller et al, 2006; Brasaemle et al, 2004), although their functional relevance in LD 
biology still remains elusive. Because LDs have hydrophobic cores, HspX could 
either associate nonspecifically to the LD, or it may be functionally involved in 
stabilizing LD-associated proteins in their native conformations. 
The LD-associated protein BCG1169c is unique to the Mycobacterium family 
(Marmiesse et al, 2004) and is not found in other prokaryotes and eukaryotes. 
Although BCG1169c has no functional annotation, it also appears to play a role in TG 
biogenesis: mutants deleted of BCG1169c displayed a TG profile similar to ∆-tgs1 
bacilli. Because of its relatively small size of 23 kDa and the absence of any 
conserved motifs indicative of known lipases (Deb et al, 2006) or acyltransferases 
(Daniel et al, 2004), we propose that BCG1169c may be a co-activator or other 
regulator of TG metabolizing enzymes; its specific functional role in TG homeostasis 
remains to be determined. 
TGs are considered important pathogenicity factors, based on the occurrence 
of M. tuberculosis containing intracellular LDs in human sputum (Garton et al, 2002; 
Garton et al, 2008). This raises the possibility that genes encoding LD-associated 
proteins could be overexpressed during virulence. Indeed, it was shown that the DosR 
operon in hypervirulent strains of the W-Beijing M. tuberculosis family is involved in 
TG buildup (Reed et al, 2007). In particular, hspX and tgs1 genes, which comprise 
this dormancy regulon, are constitutively overexpressed in W-Beijing strains (Reed et 
al, 2007 and TG-loaded M. tuberculosis isolated from human sputum (Garton et al, 
2008). Moreover, HspX is required for the growth of mycobacteria in macrophages, 
establishing a role for this chaperone during initial infection (Yuan et al, 1998). An 
additional regulator, KstR (Rv3574), that is induced in vivo (Talaat et al, 2004) and is 
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required for infection in mice (Sassetti and Rubin, 2003), links virulence to lipid 
homeostasis. Genomic phenotyping of the kstR-null mutant in M. smegmatis revealed 
that the Tet-R regulator controls expression of a large number of lipid metabolizing 
genes, including an ortholog of BCG1489c (Kendall et al, 2007). These results further 
highlight the functional link between LD-associated proteins and M. tuberculosis 
virulence. 
Results from many independent studies converge in the view that intracellular 
LDs typically share a general structure, consisting of a core of TGs and/or steryl 
esters, surrounded by a monolayer of phospholipids with a few embedded proteins 
(Zweytick et al, 2000). Subcellular localization of mycobacterial LD-associating 
proteins to the yeast LDs demonstrates that targeting and anchorage of such 
polypeptides are largely independent of the host organism. These results also strongly 
imply that the identified proteins are indeed LD-associated in mycobacteria and are 
not mere contaminations from other cellular fractions or the isolation procedure. 
These data are furthermore in agreement with other reports that (i) murine TG lipase 
localizes to yeast LDs (Kurat et al, 2006) and (ii) eukaryotic PAT (termed after the 
first three identified members: perilipin, adipophilin, and tail-interacting protein of 47 
kDa) family proteins are correctly targeted to the LDs of prokaryotes (Hanisch et al, 
2006). 
Interestingly, mycobacteria and yeast lack genes that encode for orthologs of 
PAT proteins (Miura et al, 2002), suggesting that this family of proteins may not be 
essential to the integrity of LD structure in these microorganisms. Obviously, 
regulatory mechanisms involved in TG storage and utilization between various cell 
types are quite diverse. On the other hand, a comparison of our results and a similar 
study in yeast (Athenstaedt et al, 1999) revealed that proteins with certain functions 
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are conserved in both microorganisms and include 1-acylglycerol-3-phosphate 
acyltransferase, TG lipase, and ACSL. In fact, enzymes with the latter two functions 
are also conserved in LDs of mammalian cells (Brasaemle et al, 2004; Liu et al, 
2004). This suggests functional conservation of these lipid metabolizing enzymes in a 
wide variety of prokaryotic and eukaryotic species. It furthermore demonstrates that 
these are presumably the core enzymatic functions required for LD biogenesis and 
degradation, conserved from mycobacteria to mammals. The occurrence of dual 
function activities on single polypeptides, such as the TG lipase and acyltransferase 
activities on yeast LD-associated proteins Tgl3 and Tgl5 (Rajakumari and Daum, 
2010), or the lipase and putative ACSL activity on the mycobacterial BCG1721, is 
intriguing and further highlights the complex metabolic and regulatory interplay to 
establish and maintain TG homeostasis and the importance of this process for cellular 
maintenance and survival.  
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Chapter 5 
Conclusion and Future Directions 
The success of Mycobacterium tuberculosis (Mtb) as a human pathogen lies in 
its capacity to maintain a state of persistence during chronic infection, from which it 
can reactivate upon encountering favorable conditions (e.g. host immune systems 
become suppressed) to cause active TB disease (Flynn and Chan, 2001; Manabe and 
Bishai, 2000). This presents a challenging obstacle to the elimination of TB since one-
third of the world’s population is affected (Dye, 2006), and the majority of TB 
patients carry latent TB infection, thereby constituting a major reservoir of the 
pathogen (Parrish et al, 1998). Furthermore, this metabolically inactive mycobacterial 
population is tolerant to many conventional antibiotics (Stover et al, 2000; Wayne and 
Sramek, 1994), thus making eradication of TB an even harder task to accomplish.  
Hypoxia is thought to be the one of the important stress-factors that drive Mtb 
into a state of nonreplicating persistence (NRP) in vivo (Wayne and Sohaskey, 2001). 
Tubercle bacilli have been recovered from human tuberculous lesions and necrotic 
tissues where there is a lack of oxygen and permeability (Russell et al, 1955). Mtb 
harvested from murine lungs shows a transcriptional pattern which is characteristic of 
the bacilli in an in vitro hypoxia-induced NRP model (Shi et al, 2003). Collectively, 
these findings suggest that the state of dormancy is functionally linked to reduced 
oxygen tension, therefore postulating that mycobacterial latency can be studied using 
the in vitro hypoxia-induced NRP model (Wayne and Hayes, 1996).  
Identification of metabolic processes and enzymes necessary for the tubercle 
bacilli to transit into and out of the dormant state may provide a better understanding 
of mycobacterial pathogenesis, thereby leading to novel targets for chemotherapy to 
eradicate nongrowing Mtb during persistent infection. Therefore, in this thesis, we 
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utilized various disciplines and techniques (biochemistry, bioinformatics, cell biology, 
genetics, microbiology, and pharmacology) to analyze and decipher the roles of 
triacylglycerol (TG) and its metabolic enzymes in Mycobacterium bovis BCG, an 
attenuated strain but closely related to Mtb, during hypoxic NRP phase and 
subsequently, reactivation with oxygenated air.  
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5.1 TG Metabolism in M. bovis BCG 
Recent efforts to explore the mechanisms which allow the Mtb to enter into 
dormancy and survive in the host for a long period of time have suggested that fatty 
acids (FAs) could be an important source of energy during the NRP state (Bishai, 
2000; Munoz-Elias and McKinney, 2005; Russell, 2003). In particular, TGs, triesters 
of three FAs, are postulated to be this likely source of lipids (Daniel et al, 2004). In 
fact, TGs are an efficient form of energy reserves in many organisms during long-
term survival (Stryer, 1995). 
This study demonstrated that there is an extensive accumulation and 
breakdown of TGs in M. bovis BCG during entry into and exit from hypoxia-induced 
NRP conditions, respectively (Figure 3.1). The existence of lipid droplets (LDs), the 
storage form of TGs inside bacilli, correlates well with the TG dynamics (Figure 
3.5C), and such kinetics are absent under aerobic conditions. The accumulation of 
TGs during dormancy has led to a hypothesis that these neutral lipids are important 
for survival during latency and reactivation. More importantly, if the TGs are utilized 
for energy consumption during regrowth, their hydrolysis would be required for the 
release of FAs. Indeed, the reduction of intracellular TG inclusions during regrowth is 
accompanied by the increased TG lipase activity (Figure 3.3), suggesting that TGs are 
utilized as a source of energy or as a resource by the reactivating bacilli. Our findings 
thus indicated that TGs could act as a carbon reserve for utilization during regrowth 
from hypoxia-induced dormancy. 
Using LC-MS, we showed that C18:1 fatty acyl-CoAs constitute the majority of 
FA components in all TG species during hypoxia-induced dormancy (Table 3.1). This 
FA species is also found in Tween 80, which is present in the culture media. 
Furthermore, we found that the supplemented fluorescent FAs are able to compete 
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with C18:1 for incorporation into the stored TGs of dormant bacilli (Figure 3.2). These 
results thus indicated that M. bovis BCG is able to take up exogenous FAs for the 
biosynthesis of intracellular TGs during hypoxia-induced dormancy. Our data are 
consistent with the view that mycobacteria do require host lipids as a source of energy 
for survival during persistent infection (Bishai, 2000; Russell, 2003) and prefer to 
utilize FAs during in vivo replication (Bloch and Segal, 1956; Segal and Bloch, 1957). 
Utilization of TGs as a carbon or energy source requires the activation of TG 
lipases. Tetrahydrolipstatin (THL), an inhibitor of pancreatic lipases, reduces total 
lipase activity and prevents TG breakdown of hypoxic nonreplicating mycobacteria 
when they are reactivated with oxygenated air (Figure 3.4 and 3.5). The regrowing 
cells are also unable to replicate when treated with the lipase inhibitor, likely 
attributing to the inhibition of TG hydrolysis (Figure 3.6).  
In summary, this first part of the thesis shows that TG accumulation, 
maintenance, and hydrolysis occur as bacilli enter, remain in, and exit hypoxia-
induced dormancy, respectively. At these stages, TG lipase activity is regulated to 
utilize TGs for cell survival. The bacteriostatic effect of THL on mycobacteria implies 




5.2 Lipid Droplet-associated Proteins in Mycobacteria 
Mtb utilize FAs as a carbon source during persistent infection (McKinney et 
al, 2000; Russell, 2003), and possibly keep them in the form of TGs, a class of neutral 
lipid. It is also known that mycobacteria store TGs in the form of intracellular LDs 
during dormancy (Daniel et al, 2004; Deb et al, 2009), and in TB patient sputum 
(Garton et al, 2002; Garton et al, 2008). Moreover, a direct correlation between the 
buildup of TGs and phenotypic drug-resistance in Mtb was established (Deb et al, 
2009), highlighting the importance of these lipids during latency and pathogenicity. 
TG utilization occurs when mycobacteria are subjected to a nutrient-deprived 
condition (Deb et al, 2006), or resuscitated from a hypoxic, nonreplicating state (Low 
et al, 2009). These observations highlight the important functional role of intracellular 
lipid stores during NRP and pathogen reactivation in the host. Despite the attention 
given to the roles of intracellular TGs in mycobacteria, enzymes involved in the 
anabolism and catabolism of TG remain relatively unknown. 
TGs are typically stored as cytoplasmic LDs in prokaryotes and eukaryotes 
and have been extensively studied using classical biochemical and proteomic 
approaches in the latter (Athenstaedt et al, 1999; Bartz et al, 2007; Beller et al, 2006; 
Brasaemle et al, 2004; Fujimoto et al, 2004; Liu et al, 2004; Sato et al, 2006; Wan et 
al, 2007). Identification and characterization of these factors in mycobacteria are 
expected to have a major impact on our understanding of TG homeostasis, LD 
biogenesis, and turnover in prokaryotic processes, which are critical to cellular 
maintenance and survival.  
This work has identified five proteins: Tgs1 (BCG3153c), Tgs2 (BCG3794c), 
BCG1169c, BCG1489c, and BCG1721, which are exclusively associated with LDs 
purified from hypoxia-induced NRP M. bovis BCG (Figure 4.1 and Table 4.1). 
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Disruption of genes tgs1, tgs2, BCG1169c, and BCG1489c in M. bovis BCG revealed 
that they are indeed involved in TG metabolism (Figure 4.3). Specifically, deletion of 
BCG1169c and tgs1 resulted in reduced amounts of TG species with very-long-chain 
FAs, suggesting common involvement of these two factors in TG biosynthesis (Figure 
4.3). We also characterized BCG1721, an essential bi-functional enzyme capable of 
promoting buildup and hydrolysis of TGs, depending on the metabolic state (Figure 
4.4). Dormant mycobacteria overexpressing BCG1721 with an inactive lipase domain 
displayed a phenotype of attenuated TG breakdown and regrowth upon resuscitation 
(Figure 4.5).  
Various studies have converged to a consensus that all LDs share a general 
structure, consisting of a core of TGs and/or steryl esters, surrounded by a 
phospholipids monolayer with a few protein species embedded (Zweytick et al, 
2000). If so, the trafficking of LD-associated proteins to lipid inclusions should be 
universal across all biological systems. The subcellular localization of most 
mycobacterial LD-associating proteins fused with GFP to the yeast lipid inclusions 
clearly demonstrates that the targeting and anchorage of such polypeptides are 
independent of the host organisms (Figure 4.2). These data are in agreement with 
other reports that (i) murine LD-associated TG lipase can localize to yeast lipid 
inclusions (Kurat et al, 2006), and (ii) eukaryotic PAT family proteins are targeted to 
the bacterial LDs (Hanisch et al, 2006). If the structure of TG storage provides a 
common docking site for LD-associated proteins, then how do the proteins get 
trafficked to the lipid inclusions? The answer possibly lies with the overall 
organization, not distinct sequence motifs, that govern the targeting to LDs. An 
example is that although all PAT family proteins has the ability to coat TG inclusions, 
it is not the most highly conserved sequence (around 100 amino acids located at N-
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terminus) which is responsible for the LD-localizing capacity since one of the 
members, S3-12 lacks it (Wolins et al, 2003). Rather, it has been demonstrated that it 
is the long hydrophobic domains of caveolin-1 (Ostermeyer et al, 2004) and perilipin 
A (Garcia et al, 2003) that are responsible for their localizations to intracellular TG 
inclusions, supporting the notion that LD-anchorage is mediated by structural 
conformation of proteins. It is, however, still unclear if a conserved trafficking 
mechanism exists. 
One of the most obvious differences between the LD-associated proteome of 
mycobacteria and that of eukaryotes (excluding yeast) is the existence of PAT family 
of peripheral membrane proteins in the latter group (Miura et al, 2002). Interestingly, 
mycobacteria and yeast lack genes that encode for orthologs of PAT proteins, 
suggesting that this family of proteins may not be essential to the integrity of LD 
structure in these microorganisms. Clearly, the regulatory mechanisms in TG storage 
and utilization between various cell types could be very diverse. A comparison of our 
results and yeast study (Athenstaedt et al, 1999) revealed that proteins with certain 
functions are conserved in both microorganisms. These common members include 
AGPAT, TG lipase and ACSL. In fact, enzymes with the latter two functions are also 
conserved in the LDs of mammalian cell types (Brasaemle et al, 2004; Fujimoto et al, 
2004; Liu et al, 2004). This implies a functional conservation of these lipid 
metabolizing enzymes in a wide variety of eukaryotic species. Conversely, some key 
differences are also observed, particularly the absence of patatin domain-containing 
proteins in mycobacteria. The recent discovery of ATGL in mammals (Zimmermann 
et al, 2004), Brummer lipase in Drosophila (Gronke et al, 2005), Tgl3 (Athenstaedt 
and Daum, 2003); Tgl4 (Kurat et al, 2006) lipases in yeast, noted an emerging group 
of patatin domain-containing proteins which have the capacity to bind to LDs, and to 
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mobilize the FAs from stored fats. Patatin domain was first identified in patatin, an 
abundant protein in potato tubers (Shewry, 2003), showing acyl hydrolase activity on 
lipid substrates (Andrews et al, 1988). Interestingly, albeit mycobacteria have eight 
predicted patatin domain-containing proteins in the genome (Banerji and Flieger, 
2004), none of them are associated with the LDs in this study. Perhaps they are not 
enriched enough to be detected or not related to the TG metabolism. Indeed, bacterial 
patatin-like hydrolases may possess phospholipase A activity instead (Phillips et al, 
2003; Sato et al, 2003).  
While neutral lipid metabolism is well studied in eukaryotes and some lipid-
accumulating bacteria such as R. opacus, the molecular machinery involved in the 
formation of TGs in mycobacteria is relatively unclear. All the four gene-disrupted 
and one overexpressed strains showed moderate reduction and increase in the TG 
levels respectively (Figure 4.3 and 4.4), without a complete deficit of lipid inclusions. 
This clearly indicates the complex mechanism involved in the TG metabolism. There 
could be other proteins involved, given the occurrence of multiple copies of redundant 
lipid metabolizing enzymes in Mtb (Cole et al, 1998). Metabolic enzymes involved in 
buildup and breakdown of LDs are often physically associated with this lipid storage 
(Athenstaedt et al, 1999; Bartz et al, 2007; Beller et al, 2006; Brasaemle et al, 2004; 
Fujimoto et al, 2004; Liu et al, 2004; Sato et al, 2006; Wan et al, 2007). However, a 
recent work revealed that transcriptional repression of a major LD protein has no 
effect on TG metabolism in microalgae (Moellering and Benning, 2010), thereby 
suggesting that the paradigm of TG metabolic enzymes embedding in the LDs may 
not be always true. In spite of this, based on our protein profiling, knock-out and 
overexpression data, the mycobacterial LDs appear to contain a characteristic set of 
enzymes to synthesize, store, degrade and utilize various lipids as depicted in a 
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schematic pathway (Figure 4.6). Such information provides valuable insights into TG 
homeostasis, and highlights the importance of this process for cellular maintenance 
and survival in mycobacteria. Indeed, not attacking metabolically active bacilli but 
acting to prevent reactivation and/or killing dormant mycobacteria, in combination 
with the current anti-TB drugs may reduce treatment time and thus advance the 
chemotherapy of Mtb. Of note, the demonstrated functional role of BCG1721 to 
support mycobacterial growth upon resuscitation will make this novel LD-associated 
factor a potential new target for therapeutic intervention. 
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5.3 Future Work 
Future work and direction to better understand the TG metabolism in 
mycobacteria should include the following objectives: 
 
1. If TG accumulation is essential to the mycobacteria during hypoxia-induced 
dormancy, it will be interesting to abolish TG biosynthesis and observe its 
phenotype. However, the present work did not manage to generate “fat-free” 
bacilli due to a possible and common gene redundancy problem, since only 
single gene-disrupted mutants were generated. Double tgs1 and tgs2 gene-
deletion mutants could be instrumental to obtain a mycobacterial strain which 
is devoid of lipid inclusions. 
 
2. TG synthase gene, tgs1, under the control of the dormancy regulon (DosR) is 
constitutively active to produce massive TGs in the hypervirulent W-Beijing 
Mtb strains, and lead to a hypothesis that these lipids provide a growth 
advantage for the bacilli to survive during latent infection (Reed et al, 2007). 
Generating and phenotyping W-Beijing Mtb mutants deleted of either tgs1 or 
dosR will be useful to validate this postulation.  
 
3. With reference to the significant TG-buildup capacity of W-Beijing Mtb 
strains, it will be interesting to know if the genes encoding LD-associated 
proteins are also upregulated in a similar fashion to that of DosR regulon. 
These proteins may directly contribute to the survival fitness and 
hypervirulence of this particular lineage, hence targeting these factors could be 
appropriate for therapeutic intervention.  
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4. The mycobacterial targets of THL remain largely elusive, even though they 
are likely to be related to the lipid metabolism. Identification of these factors is 
crucial for drug discovery process so as to produce a more effective series of 
THL analogues. To determine these targets, a novel chemical proteomic 
approach that has identified putative targets of THL in cancer cells 
successfully may be employed (Yang et al, 2009).  
 
5. Since patatin-like proteins have been demonstrated to have TG lipase activity 
in various eukaryotic organisms, it is possible that one of the eight patatin 
domain-containing proteins in Mtb may possess the capacity to hydrolyze 
LDs. Recombinant mycobacterial patatin-like proteins should be generated 
and analyzed to test out this hypothesis.  
 
6. BCG1721 is characterized as an essential and presumably bi-functional 
enzyme with lipase and potential ACSL activities on a single polypeptide 
chain in M. bovis BCG. The two functions could be functionally linked: FA 
released by lipase is transferred to ACSL for activation into nonreactive 
intermediates. Thus it will be interesting to determine the three-dimensional 
structure of the bi-functional enzyme in order to validate the biophysical basis 
of this hypothetical process, and determine the target’s druggability (Owens, 
2007). However, its large (107-kDa) and hydrophobic nature make it 
extremely challenging to produce a soluble recombinant protein which is 
essential for crystallization process. 
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7. This work suggests that BCG1721, a functional lipase residing on LDs is 
inactive during dormancy, but is able to hydrolyze TGs upon reactivation. The 
molecular mechanism involved in this regulation remains unknown. Studies 
have demonstrated that eukaryotic LD-associated lipase is activated by either a 
cofactor (Lass et al, 2006) , or a cell growth-related kinase (Kurat et al, 2009). 
In the light of this, future work should focus on the possible interacting 
partners through affinity binding studies, in order to elucidate the molecular 
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Annex 1: TG metabolism in M. bovis BCG during logarithmic, aerated 
stationary, hypoxia-induced dormancy, and regrowth phases. LC-MS analysis of 
the total TG content in lipid extracts of M. bovis BCG under different conditions. The 
bars indicate the means, and the error bars indicate the standard deviations (n = 3). *, 
P < 0.05 for a comparison with the TG levels at log, aerated stationary and regrowth 




Annex 2: INH does not inhibit total TG lipase activity. Cell lysate of a regrowing 
mycobacterial culture was incubated with INH for 30 min prior to determination of 
the total TG lipase activity. The data are means ± standard deviations (n = 3). RFU, 





Annex 3: Effect of THL and INH on cell growth during different physiological 
states. The cultures used contained bacilli in the logarithmic (d3A and d6A), aerated 
stationary (d10A and d13A), hypoxia-induced dormant (d20 and d23), and regrowth 
(d3R) phases (d, day; A, aeration; R, regrowth). All cultures were treated with or 
without THL (80 μM) or INH (1 μM) for 3 days. The numbers of CFU were 
determined under various growth conditions, and then appropriate dilutions of cells 
were plated. The bars indicate the means, and the error bars indicate the standard 
deviations (n = 3). *, P < 0.05 for a comparison with the number of CFU in the 





Annex 4: Effect of THL and INH on TG metabolism during different 
physiological states. The cultures used contained bacilli in the logarithmic (d3A and 
d6A), aerated stationary (d10A and d13A), hypoxia-induced dormant (d20 and d23), 
and regrowth (d3R) phases (d, day; A, aeration; R, regrowth). All cultures were 
treated with or without THL (80 μM) or INH (1 μM) for 3 days. TLC analysis of TG 
levels in M. bovis BCG under different growth conditions and with different drug 





Annex 5: Gene deletion of lipY affects TG breakdown at the initial stage of 
regrowth. (A) TLC analysis of TG levels in M. bovis BCG wild type or gene-null (∆-
lipY) mutant under dormancy (d20), regrowth (d1R) and regrowth (d3R) phases (d, 
day; R, regrowth). The values are the amounts of TGs as determined by densitometry. 
(B) Total TG lipase activities of mycobacterial extracts in the hypoxia-induced 
dormant, and regrowth phases. Black bar, wild type; white bar, ∆-lipY. The bars 





Annex 6: Gene deletion of lipY affects cell growth at the initial stage of regrowth. 
The numbers of CFU were determined in M. bovis BCG wild type or gene-null (∆-
lipY) mutant under dormancy (d20), regrowth (d1R) and regrowth (d3R) phases (d, 
day; R, regrowth), and then appropriate dilutions of cells were plated. Black bar, wild 
type; white bar, ∆-lipY. The bars indicate means, and the error bars indicate standard 




Annex 7: Neutral lipid analysis of different subcellular fractions. (A) Schematic 
representation of sucrose gradient ultracentrifugation in a tube showing different 
subcellular fractions. Fractions 1 and 2 refer to the interphases between 5-20% and 0-
5% respectively, while fraction 3 refers to top floating layer. Note that the bottom 
phase (likely cytosolic components) was yellowish in color, indicating its high protein 
concentration. The orange colored portion represents the resulting pellet consisting of 
unbroken bacteria and cell debris. (B) TLC analysis of different subcellular fractions. 
Lanes 1-3 correspond to the same fraction numbers in panel A. Lipids were extracted 
from each fraction using chloroform/methanol (2:1, v/v), spotted on Silica Gel 60, 
developed in n-hexane/diethyl ether/formic acid (45:5:1, v/v/v), and visualized with 
iodine vapor. Note that the floating material (lane 3) contained a significant amount of 
TGs compared to the other fractions, demonstrating that this layer was highly 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Annex 9: Disruption of genes encoding LD-associated proteins reduces TG 
accumulation during hypoxia-induced nonreplicating state. LC-MS analysis of 
TG levels in different mutants, (A) ∆-tgs1; (B) ∆-tgs2; (C) ∆-BCG1169c; (D) ∆-
BCG1489c in hypoxic nonreplicating phase. TG levels refer to the neutral lipid 
(carbon atoms: double bonds). Black bar: WT, wild type strain; white bar: ∆, 
genetically disrupted strain; and grey bar: C-∆, complemented strain. Data is 




Annex 10: Active serine residue 150 was important for the TG lipase activity of 
BCG1721. (A) Yeast ∆-tgl3∆-tgl4 double mutant transformed with empty pYEX4T-1 
plasmid, BCG1721, BCG1721(S150A) and tgl4 were assayed for lipase activity during 
induction of TG hydolysis. Note the decrease of lipase activity when S150 is changed 
to into alanine residue in BCG1721. (B) Western blot analysis of GST-tagged 
BCG1721, BCG1721(S150A) and Tgl4 proteins, confirming their expressions in the 
transformed double gene-null mutant. Segment of a Coomassie Blue-stained gel is 
also included to demonstrate equal loading for the immunoblot. Data is representative 




Annex 11: Overexpression of BCG1721 leads to reduced storage of TGs with 
very-long-chain FAs in replicating mycobacteria. LC-MS analysis of FAs in TG 
levels in different mycobacterial strains, WT, pBCG1721 and pBCG1721(S150A) 
during logarithmic phase. TG levels refer to the neutral lipid (carbon atoms: double 
bonds). Black bar: WT, wild type strain; white bar: pBCG1721; and grey bar: 
pBCG1721(S150A). Data is represented as mean values ± standard deviations (n = 3). 




Annex 12: Genomic deletion of LD-associated proteins from M. bovis BCG 
genome. Schematic representation of the genome region of the wild type (WT) and 
deletion mutant (KO) strains showing the relative gene organization of BCG1169c 
(A), BCG1489c (C), tgs1 (E), and tgs2 (G), the locations of the probes and BamHI 
restriction sites, and the corresponding fragment lengths. The target gene was 
disrupted by allelic exchange with a hygromycin resistance cassette (hyg), resulting in 
a gene-null mutant. Gene deletions in mutants were confirmed by Southern blotting. 
Genomic DNA of WT and KO strains [BCG1169c (B), BCG1489c (D), tgs1 (F), and 
tgs2 (H)] digested with BamHI were probed for the modification of locus (Probe 1, 
left panel), the presence of intact gene (Probe 2, middle panel) and hygromycin 
resistance cassette (Probe 3, right panel).  
 
